id	sid	tid	token	lemma	pos
dhrp-35	1	1	2021	2021	NUM
dhrp-35	1	2	,	,	PUNCT
dhrp-35	1	3	vol	vol	NOUN
dhrp-35	1	4	.	.	NOUN
dhrp-35	1	5	1	1	NUM
dhrp-35	1	6	(	(	PUNCT
dhrp-35	1	7	s5	s5	NOUN
dhrp-35	1	8	)	)	PUNCT
dhrp-35	1	9	7	7	NUM
dhrp-35	1	10	-	-	SYM
dhrp-35	1	11	10	10	NUM
dhrp-35	1	12	https://doi.org/10.47488/dhrp.v1is5.35	https://doi.org/10.47488/dhrp.v1is5.35	NOUN
dhrp-35	1	13	http://dhrproceedings.org	http://dhrproceedings.org	PROPN
dhrp-35	1	14	7	7	NUM
dhrp-35	1	15	©	©	PROPN
dhrp-35	1	16	dhr	dhr	PROPN
dhrp-35	1	17	health	health	PROPN
dhrp-35	1	18	institute	institute	PROPN
dhrp-35	1	19	for	for	ADP
dhrp-35	1	20	research	research	NOUN
dhrp-35	1	21	and	and	CCONJ
dhrp-35	1	22	development	development	NOUN
dhrp-35	1	23	commentary	commentary	NOUN
dhrp-35	1	24	the	the	DET
dhrp-35	1	25	newly	newly	ADV
dhrp-35	1	26	detected	detect	VERB
dhrp-35	1	27	b.1.1.529	b.1.1.529	ADV
dhrp-35	1	28	(	(	PUNCT
dhrp-35	1	29	omicron	omicron	PROPN
dhrp-35	1	30	)	)	PUNCT
dhrp-35	1	31	variant	variant	NOUN
dhrp-35	1	32	of	of	ADP
dhrp-35	1	33	sars	sar	NOUN
dhrp-35	1	34	-	-	PUNCT
dhrp-35	1	35	cov-2	cov-2	NOUN
dhrp-35	1	36	with	with	ADP
dhrp-35	1	37	multiple	multiple	ADJ
dhrp-35	1	38	mutations	mutation	NOUN
dhrp-35	1	39	implications	implication	NOUN
dhrp-35	1	40	for	for	ADP
dhrp-35	1	41	transmission	transmission	NOUN
dhrp-35	1	42	,	,	PUNCT
dhrp-35	1	43	diagnostics	diagnostic	NOUN
dhrp-35	1	44	,	,	PUNCT
dhrp-35	1	45	therapeutics	therapeutic	NOUN
dhrp-35	1	46	,	,	PUNCT
dhrp-35	1	47	and	and	CCONJ
dhrp-35	1	48	immune	immune	ADJ
dhrp-35	1	49	evasion	evasion	NOUN
dhrp-35	1	50	sohail	sohail	PROPN
dhrp-35	1	51	rao	rao	PROPN
dhrp-35	1	52	,	,	PUNCT
dhrp-35	1	53	md	md	PROPN
dhrp-35	1	54	,	,	PUNCT
dhrp-35	1	55	ma	ma	PROPN
dhrp-35	1	56	,	,	PUNCT
dhrp-35	1	57	dphil1	dphil1	PROPN
dhrp-35	1	58	,	,	PUNCT
dhrp-35	1	59	2	2	NUM
dhrp-35	1	60	and	and	CCONJ
dhrp-35	1	61	manish	manish	PROPN
dhrp-35	1	62	singh	singh	PROPN
dhrp-35	1	63	,	,	PUNCT
dhrp-35	1	64	md	md	PROPN
dhrp-35	1	65	,	,	PUNCT
dhrp-35	1	66	facs3	facs3	X
dhrp-35	1	67	1	1	NUM
dhrp-35	1	68	executive	executive	ADJ
dhrp-35	1	69	vice	vice	NOUN
dhrp-35	1	70	president	president	NOUN
dhrp-35	1	71	,	,	PUNCT
dhrp-35	1	72	dhr	dhr	PROPN
dhrp-35	1	73	health	health	PROPN
dhrp-35	1	74	,	,	PUNCT
dhrp-35	1	75	5501	5501	NUM
dhrp-35	1	76	s.	s.	PROPN
dhrp-35	1	77	mccoll	mccoll	PROPN
dhrp-35	1	78	road	road	PROPN
dhrp-35	1	79	,	,	PUNCT
dhrp-35	1	80	edinburg	edinburg	PROPN
dhrp-35	1	81	,	,	PUNCT
dhrp-35	1	82	texas	texas	PROPN
dhrp-35	1	83	78539	78539	NUM
dhrp-35	1	84	and	and	CCONJ
dhrp-35	1	85	president	president	PROPN
dhrp-35	1	86	&	&	CCONJ
dhrp-35	1	87	chief	chief	ADJ
dhrp-35	1	88	executive	executive	ADJ
dhrp-35	1	89	officer	officer	NOUN
dhrp-35	1	90	,	,	PUNCT
dhrp-35	1	91	dhr	dhr	PROPN
dhrp-35	1	92	health	health	PROPN
dhrp-35	1	93	institute	institute	PROPN
dhrp-35	1	94	for	for	ADP
dhrp-35	1	95	research	research	PROPN
dhrp-35	1	96	&	&	CCONJ
dhrp-35	1	97	development	development	PROPN
dhrp-35	1	98	,	,	PUNCT
dhrp-35	1	99	5323	5323	NUM
dhrp-35	1	100	s.	s.	PROPN
dhrp-35	1	101	mccoll	mccoll	PROPN
dhrp-35	1	102	road	road	PROPN
dhrp-35	1	103	,	,	PUNCT
dhrp-35	1	104	edinburg	edinburg	PROPN
dhrp-35	1	105	,	,	PUNCT
dhrp-35	1	106	texas	texas	PROPN
dhrp-35	1	107	78539	78539	NUM
dhrp-35	1	108	.	.	PUNCT
dhrp-35	2	1	orcid	orcid	NOUN
dhrp-35	2	2	:	:	PUNCT
dhrp-35	2	3	https://orcid.org/0000-0001-5027-9992	https://orcid.org/0000-0001-5027-9992	PROPN
dhrp-35	2	4	2	2	NUM
dhrp-35	2	5	correspondence	correspondence	NOUN
dhrp-35	2	6	should	should	AUX
dhrp-35	2	7	be	be	AUX
dhrp-35	2	8	addressed	address	VERB
dhrp-35	2	9	to	to	ADP
dhrp-35	2	10	:	:	PUNCT
dhrp-35	2	11	sohail	sohail	PROPN
dhrp-35	2	12	rao	rao	PROPN
dhrp-35	2	13	,	,	PUNCT
dhrp-35	2	14	md	md	PROPN
dhrp-35	2	15	,	,	PUNCT
dhrp-35	2	16	ma	ma	PROPN
dhrp-35	2	17	,	,	PUNCT
dhrp-35	2	18	dphil	dphil	NOUN
dhrp-35	2	19	.	.	PUNCT
dhrp-35	2	20	,	,	PUNCT
dhrp-35	2	21	dhr	dhr	PROPN
dhrp-35	2	22	health	health	PROPN
dhrp-35	2	23	institute	institute	PROPN
dhrp-35	2	24	for	for	ADP
dhrp-35	2	25	research	research	PROPN
dhrp-35	2	26	&	&	CCONJ
dhrp-35	2	27	development	development	PROPN
dhrp-35	2	28	,	,	PUNCT
dhrp-35	2	29	5323	5323	NUM
dhrp-35	2	30	s.	s.	PROPN
dhrp-35	2	31	mccoll	mccoll	PROPN
dhrp-35	2	32	road	road	PROPN
dhrp-35	2	33	,	,	PUNCT
dhrp-35	2	34	edinburg	edinburg	PROPN
dhrp-35	2	35	,	,	PUNCT
dhrp-35	2	36	texas	texas	PROPN
dhrp-35	2	37	78539	78539	NUM
dhrp-35	2	38	.	.	PUNCT
dhrp-35	3	1	tel	tel	ADP
dhrp-35	3	2	:	:	PUNCT
dhrp-35	3	3	(	(	PUNCT
dhrp-35	3	4	956	956	NUM
dhrp-35	3	5	)	)	PUNCT
dhrp-35	3	6	362	362	NUM
dhrp-35	3	7	-	-	SYM
dhrp-35	3	8	2387	2387	NUM
dhrp-35	3	9	.	.	PUNCT
dhrp-35	4	1	e	e	X
dhrp-35	4	2	-	-	NOUN
dhrp-35	4	3	mail	mail	NOUN
dhrp-35	4	4	:	:	PUNCT
dhrp-35	4	5	s.rao@dhr-rgv.com	s.rao@dhr-rgv.com	X
dhrp-35	4	6	3	3	NUM
dhrp-35	4	7	chief	chief	ADJ
dhrp-35	4	8	executive	executive	ADJ
dhrp-35	4	9	officer	officer	NOUN
dhrp-35	4	10	,	,	PUNCT
dhrp-35	4	11	dhr	dhr	PROPN
dhrp-35	4	12	health	health	PROPN
dhrp-35	4	13	,	,	PUNCT
dhrp-35	4	14	5501	5501	NUM
dhrp-35	4	15	s.	s.	PROPN
dhrp-35	4	16	mccoll	mccoll	PROPN
dhrp-35	4	17	road	road	PROPN
dhrp-35	4	18	,	,	PUNCT
dhrp-35	4	19	edinburg	edinburg	PROPN
dhrp-35	4	20	tx	tx	PROPN
dhrp-35	4	21	78539	78539	NUM
dhrp-35	4	22	and	and	CCONJ
dhrp-35	4	23	dhr	dhr	PROPN
dhrp-35	4	24	health	health	PROPN
dhrp-35	4	25	bariatric	bariatric	ADJ
dhrp-35	4	26	and	and	CCONJ
dhrp-35	4	27	metabolic	metabolic	PROPN
dhrp-35	4	28	institute	institute	NOUN
dhrp-35	4	29	,	,	PUNCT
dhrp-35	4	30	500	500	NUM
dhrp-35	4	31	raphael	raphael	PROPN
dhrp-35	4	32	drive	drive	PROPN
dhrp-35	4	33	,	,	PUNCT
dhrp-35	4	34	edinburg	edinburg	PROPN
dhrp-35	4	35	,	,	PUNCT
dhrp-35	4	36	tx	tx	PROPN
dhrp-35	4	37	78539	78539	NUM
dhrp-35	4	38	orcid	orcid	NOUN
dhrp-35	4	39	:	:	PUNCT
dhrp-35	4	40	manish	manish	PROPN
dhrp-35	4	41	singh	singh	PROPN
dhrp-35	4	42	:	:	PUNCT
dhrp-35	5	1	https://orcid.org/0000-0003-4146-3282	https://orcid.org/0000-0003-4146-3282	PROPN
dhrp-35	5	2	received	receive	VERB
dhrp-35	5	3	11/27/2021	11/27/2021	NUM
dhrp-35	5	4	accepted	accept	VERB
dhrp-35	5	5	for	for	ADP
dhrp-35	5	6	publication	publication	NOUN
dhrp-35	5	7	11/29/2021	11/29/2021	NUM
dhrp-35	5	8	published	publish	VERB
dhrp-35	5	9	11/29/2021	11/29/2021	NUM
dhrp-35	5	10	keywords	keyword	NOUN
dhrp-35	5	11	:	:	PUNCT
dhrp-35	5	12	covid-19	covid-19	PROPN
dhrp-35	5	13	;	;	PUNCT
dhrp-35	5	14	sars	sar	NOUN
dhrp-35	5	15	-	-	PUNCT
dhrp-35	5	16	cov-2	cov-2	NUM
dhrp-35	5	17	;	;	PUNCT
dhrp-35	5	18	b.1.1.529	b.1.1.529	ADV
dhrp-35	5	19	;	;	PUNCT
dhrp-35	5	20	omicron	omicron	PROPN
dhrp-35	5	21	variant	variant	NOUN
dhrp-35	5	22	;	;	PUNCT
dhrp-35	5	23	vbm	vbm	PROPN
dhrp-35	5	24	:	:	PUNCT
dhrp-35	5	25	variant	variant	NOUN
dhrp-35	5	26	being	be	AUX
dhrp-35	5	27	monitored	monitor	VERB
dhrp-35	5	28	;	;	PUNCT
dhrp-35	5	29	voi	voi	X
dhrp-35	5	30	:	:	PUNCT
dhrp-35	5	31	variant	variant	NOUN
dhrp-35	5	32	of	of	ADP
dhrp-35	5	33	interest	interest	NOUN
dhrp-35	5	34	;	;	PUNCT
dhrp-35	5	35	voc	voc	NOUN
dhrp-35	5	36	:	:	PUNCT
dhrp-35	5	37	variant	variant	NOUN
dhrp-35	5	38	of	of	ADP
dhrp-35	5	39	concern	concern	NOUN
dhrp-35	5	40	;	;	PUNCT
dhrp-35	5	41	vohc	vohc	NOUN
dhrp-35	5	42	:	:	PUNCT
dhrp-35	5	43	variant	variant	NOUN
dhrp-35	5	44	of	of	ADP
dhrp-35	5	45	high	high	ADJ
dhrp-35	5	46	concern	concern	NOUN
dhrp-35	5	47	;	;	PUNCT
dhrp-35	5	48	sdft	sdft	ADJ
dhrp-35	5	49	:	:	PUNCT
dhrp-35	5	50	s	s	NOUN
dhrp-35	5	51	-	-	PUNCT
dhrp-35	5	52	gene	gene	NOUN
dhrp-35	5	53	target	target	NOUN
dhrp-35	5	54	failure	failure	NOUN
dhrp-35	5	55	;	;	PUNCT
dhrp-35	5	56	ace2	ace2	PROPN
dhrp-35	5	57	:	:	PUNCT
dhrp-35	5	58	angiotensin	angiotensin	NOUN
dhrp-35	5	59	-	-	PUNCT
dhrp-35	5	60	converting	convert	VERB
dhrp-35	5	61	enzyme	enzyme	NOUN
dhrp-35	5	62	2	2	NUM
dhrp-35	5	63	;	;	PUNCT
dhrp-35	5	64	cdc	cdc	PROPN
dhrp-35	5	65	:	:	PUNCT
dhrp-35	5	66	center	center	NOUN
dhrp-35	5	67	for	for	ADP
dhrp-35	5	68	disease	disease	NOUN
dhrp-35	5	69	control	control	NOUN
dhrp-35	5	70	and	and	CCONJ
dhrp-35	5	71	prevention	prevention	VERB
dhrp-35	5	72	the	the	DET
dhrp-35	5	73	global	global	ADJ
dhrp-35	5	74	and	and	CCONJ
dhrp-35	5	75	regional	regional	ADJ
dhrp-35	5	76	impact	impact	NOUN
dhrp-35	5	77	of	of	ADP
dhrp-35	5	78	sars	sar	NOUN
dhrp-35	5	79	-	-	PUNCT
dhrp-35	5	80	cov-2	cov-2	NOUN
dhrp-35	5	81	pandemic	pandemic	NOUN
dhrp-35	5	82	continues	continue	VERB
dhrp-35	5	83	to	to	PART
dhrp-35	5	84	be	be	AUX
dhrp-35	5	85	a	a	DET
dhrp-35	5	86	source	source	NOUN
dhrp-35	5	87	of	of	ADP
dhrp-35	5	88	grave	grave	ADJ
dhrp-35	5	89	concern	concern	NOUN
dhrp-35	5	90	.	.	PUNCT
dhrp-35	6	1	while	while	SCONJ
dhrp-35	6	2	the	the	DET
dhrp-35	6	3	availability	availability	NOUN
dhrp-35	6	4	of	of	ADP
dhrp-35	6	5	vaccines	vaccine	NOUN
dhrp-35	6	6	against	against	ADP
dhrp-35	6	7	the	the	DET
dhrp-35	6	8	sars	sar	NOUN
dhrp-35	6	9	-	-	PUNCT
dhrp-35	6	10	cov-2	cov-2	PART
dhrp-35	6	11	virus	virus	NOUN
dhrp-35	6	12	may	may	AUX
dhrp-35	6	13	have	have	AUX
dhrp-35	6	14	partially	partially	ADV
dhrp-35	6	15	assuaged	assuage	VERB
dhrp-35	6	16	this	this	DET
dhrp-35	6	17	anxiety	anxiety	NOUN
dhrp-35	6	18	in	in	ADP
dhrp-35	6	19	certain	certain	ADJ
dhrp-35	6	20	parts	part	NOUN
dhrp-35	6	21	of	of	ADP
dhrp-35	6	22	the	the	DET
dhrp-35	6	23	world	world	NOUN
dhrp-35	6	24	,	,	PUNCT
dhrp-35	6	25	it	it	PRON
dhrp-35	6	26	remains	remain	VERB
dhrp-35	6	27	a	a	DET
dhrp-35	6	28	prevailing	prevail	VERB
dhrp-35	6	29	and	and	CCONJ
dhrp-35	6	30	unpretentious	unpretentious	ADJ
dhrp-35	6	31	global	global	ADJ
dhrp-35	6	32	public	public	ADJ
dhrp-35	6	33	health	health	NOUN
dhrp-35	6	34	crisis	crisis	NOUN
dhrp-35	6	35	.	.	PUNCT
dhrp-35	7	1	the	the	DET
dhrp-35	7	2	latter	latter	ADJ
dhrp-35	7	3	outcome	outcome	NOUN
dhrp-35	7	4	is	be	AUX
dhrp-35	7	5	fueled	fuel	VERB
dhrp-35	7	6	by	by	ADP
dhrp-35	7	7	the	the	DET
dhrp-35	7	8	convergence	convergence	NOUN
dhrp-35	7	9	of	of	ADP
dhrp-35	7	10	several	several	ADJ
dhrp-35	7	11	factors	factor	NOUN
dhrp-35	7	12	which	which	PRON
dhrp-35	7	13	include	include	VERB
dhrp-35	7	14	(	(	PUNCT
dhrp-35	7	15	but	but	CCONJ
dhrp-35	7	16	not	not	PART
dhrp-35	7	17	limited	limit	VERB
dhrp-35	7	18	to	to	ADP
dhrp-35	7	19	)	)	PUNCT
dhrp-35	7	20	the	the	DET
dhrp-35	7	21	lack	lack	NOUN
dhrp-35	7	22	of	of	ADP
dhrp-35	7	23	availability	availability	NOUN
dhrp-35	7	24	of	of	ADP
dhrp-35	7	25	adequate	adequate	ADJ
dhrp-35	7	26	number	number	NOUN
dhrp-35	7	27	of	of	ADP
dhrp-35	7	28	vaccines	vaccine	NOUN
dhrp-35	7	29	;	;	PUNCT
dhrp-35	7	30	poor	poor	ADJ
dhrp-35	7	31	socioeconomic	socioeconomic	ADJ
dhrp-35	7	32	conditions	condition	NOUN
dhrp-35	7	33	;	;	PUNCT
dhrp-35	7	34	vaccine	vaccine	NOUN
dhrp-35	7	35	hesitancy	hesitancy	NOUN
dhrp-35	7	36	;	;	PUNCT
dhrp-35	7	37	and	and	CCONJ
dhrp-35	7	38	rampant	rampant	ADJ
dhrp-35	7	39	proliferation	proliferation	NOUN
dhrp-35	7	40	of	of	ADP
dhrp-35	7	41	misinformation	misinformation	NOUN
dhrp-35	7	42	on	on	ADP
dhrp-35	7	43	the	the	DET
dhrp-35	7	44	social	social	ADJ
dhrp-35	7	45	media	medium	NOUN
dhrp-35	7	46	.	.	PUNCT
dhrp-35	8	1	to	to	ADP
dhrp-35	8	2	date	date	NOUN
dhrp-35	8	3	,	,	PUNCT
dhrp-35	8	4	sars	sar	NOUN
dhrp-35	8	5	-	-	PUNCT
dhrp-35	8	6	cov-2	cov-2	NOUN
dhrp-35	8	7	pandemic	pandemic	NOUN
dhrp-35	8	8	has	have	AUX
dhrp-35	8	9	infected	infect	VERB
dhrp-35	8	10	over	over	ADP
dhrp-35	8	11	48	48	NUM
dhrp-35	8	12	million	million	NUM
dhrp-35	8	13	people	people	NOUN
dhrp-35	8	14	in	in	ADP
dhrp-35	8	15	the	the	DET
dhrp-35	8	16	united	united	PROPN
dhrp-35	8	17	states	states	PROPN
dhrp-35	8	18	resulting	result	VERB
dhrp-35	8	19	in	in	ADP
dhrp-35	8	20	the	the	DET
dhrp-35	8	21	death	death	NOUN
dhrp-35	8	22	of	of	ADP
dhrp-35	8	23	over	over	ADP
dhrp-35	8	24	777	777	NUM
dhrp-35	8	25	thousand	thousand	NUM
dhrp-35	8	26	(	(	PUNCT
dhrp-35	8	27	1	1	NUM
dhrp-35	8	28	)	)	PUNCT
dhrp-35	8	29	.	.	PUNCT
dhrp-35	9	1	it	it	PRON
dhrp-35	9	2	is	be	AUX
dhrp-35	9	3	noteworthy	noteworthy	ADJ
dhrp-35	9	4	that	that	SCONJ
dhrp-35	9	5	to	to	ADP
dhrp-35	9	6	a	a	DET
dhrp-35	9	7	large	large	ADJ
dhrp-35	9	8	extent	extent	NOUN
dhrp-35	9	9	,	,	PUNCT
dhrp-35	9	10	refusal	refusal	NOUN
dhrp-35	9	11	by	by	ADP
dhrp-35	9	12	hominoid	hominoid	NOUN
dhrp-35	9	13	to	to	PART
dhrp-35	9	14	get	get	AUX
dhrp-35	9	15	vaccinated	vaccinate	VERB
dhrp-35	9	16	in	in	ADP
dhrp-35	9	17	the	the	DET
dhrp-35	9	18	united	united	PROPN
dhrp-35	9	19	states	states	PROPN
dhrp-35	9	20	continues	continue	VERB
dhrp-35	9	21	to	to	PART
dhrp-35	9	22	be	be	AUX
dhrp-35	9	23	a	a	DET
dhrp-35	9	24	source	source	NOUN
dhrp-35	9	25	of	of	ADP
dhrp-35	9	26	much	much	ADJ
dhrp-35	9	27	consternation	consternation	NOUN
dhrp-35	9	28	.	.	PUNCT
dhrp-35	10	1	not	not	PART
dhrp-35	10	2	only	only	ADV
dhrp-35	10	3	do	do	AUX
dhrp-35	10	4	unvaccinated	unvaccinated	ADJ
dhrp-35	10	5	people	people	NOUN
dhrp-35	10	6	have	have	VERB
dhrp-35	10	7	a	a	DET
dhrp-35	10	8	much	much	ADV
dhrp-35	10	9	higher	high	ADJ
dhrp-35	10	10	rate	rate	NOUN
dhrp-35	10	11	of	of	ADP
dhrp-35	10	12	infection	infection	NOUN
dhrp-35	10	13	and	and	CCONJ
dhrp-35	10	14	hospitalization	hospitalization	NOUN
dhrp-35	10	15	,	,	PUNCT
dhrp-35	10	16	but	but	CCONJ
dhrp-35	10	17	they	they	PRON
dhrp-35	10	18	are	be	AUX
dhrp-35	10	19	also	also	ADV
dhrp-35	10	20	a	a	DET
dhrp-35	10	21	very	very	ADV
dhrp-35	10	22	fertile	fertile	ADJ
dhrp-35	10	23	source	source	NOUN
dhrp-35	10	24	for	for	ADP
dhrp-35	10	25	generation	generation	NOUN
dhrp-35	10	26	of	of	ADP
dhrp-35	10	27	sars	sar	NOUN
dhrp-35	10	28	-	-	PUNCT
dhrp-35	10	29	cov-2	cov-2	NOUN
dhrp-35	10	30	variants	variant	NOUN
dhrp-35	10	31	.	.	PUNCT
dhrp-35	11	1	since	since	SCONJ
dhrp-35	11	2	the	the	DET
dhrp-35	11	3	identification	identification	NOUN
dhrp-35	11	4	of	of	ADP
dhrp-35	11	5	the	the	DET
dhrp-35	11	6	first	first	ADJ
dhrp-35	11	7	infected	infect	VERB
dhrp-35	11	8	case	case	NOUN
dhrp-35	11	9	of	of	ADP
dhrp-35	11	10	covid-19	covid-19	PROPN
dhrp-35	11	11	in	in	ADP
dhrp-35	11	12	wuhan	wuhan	PROPN
dhrp-35	11	13	,	,	PUNCT
dhrp-35	11	14	china	china	PROPN
dhrp-35	11	15	in	in	ADP
dhrp-35	11	16	december	december	PROPN
dhrp-35	11	17	2019	2019	NUM
dhrp-35	11	18	,	,	PUNCT
dhrp-35	11	19	the	the	DET
dhrp-35	11	20	world	world	NOUN
dhrp-35	11	21	has	have	AUX
dhrp-35	11	22	witnessed	witness	VERB
dhrp-35	11	23	multiple	multiple	ADJ
dhrp-35	11	24	peaks	peak	NOUN
dhrp-35	11	25	of	of	ADP
dhrp-35	11	26	resurgence	resurgence	NOUN
dhrp-35	11	27	of	of	ADP
dhrp-35	11	28	covid-19	covid-19	PROPN
dhrp-35	11	29	pandemic	pandemic	NOUN
dhrp-35	11	30	largely	largely	ADV
dhrp-35	11	31	as	as	ADP
dhrp-35	11	32	a	a	DET
dhrp-35	11	33	consequence	consequence	NOUN
dhrp-35	11	34	of	of	ADP
dhrp-35	11	35	mutations	mutation	NOUN
dhrp-35	11	36	in	in	ADP
dhrp-35	11	37	the	the	DET
dhrp-35	11	38	sars	sar	NOUN
dhrp-35	11	39	-	-	PUNCT
dhrp-35	11	40	cov-2	cov-2	NOUN
dhrp-35	11	41	with	with	ADP
dhrp-35	11	42	enhanced	enhanced	ADJ
dhrp-35	11	43	transmissibility	transmissibility	NOUN
dhrp-35	11	44	and	and	CCONJ
dhrp-35	11	45	infectivity	infectivity	NOUN
dhrp-35	11	46	.	.	PUNCT
dhrp-35	12	1	the	the	DET
dhrp-35	12	2	us	us	PROPN
dhrp-35	12	3	sars	sars	PROPN
dhrp-35	12	4	-	-	PUNCT
dhrp-35	12	5	cov-2	cov-2	PART
dhrp-35	12	6	interagency	interagency	NOUN
dhrp-35	12	7	group	group	NOUN
dhrp-35	12	8	(	(	PUNCT
dhrp-35	12	9	sig	sig	NOUN
dhrp-35	12	10	)	)	PUNCT
dhrp-35	12	11	has	have	VERB
dhrp-35	12	12	delineated	delineate	VERB
dhrp-35	12	13	sars	sar	NOUN
dhrp-35	12	14	-	-	PUNCT
dhrp-35	12	15	cov-2	cov-2	NOUN
dhrp-35	12	16	variants	variant	NOUN
dhrp-35	12	17	into	into	ADP
dhrp-35	12	18	four	four	NUM
dhrp-35	12	19	distinct	distinct	ADJ
dhrp-35	12	20	categories	category	NOUN
dhrp-35	12	21	(	(	PUNCT
dhrp-35	12	22	table	table	NOUN
dhrp-35	12	23	1	1	NUM
dhrp-35	12	24	)	)	PUNCT
dhrp-35	12	25	.	.	PUNCT
dhrp-35	13	1	to	to	ADP
dhrp-35	13	2	date	date	NOUN
dhrp-35	13	3	,	,	PUNCT
dhrp-35	13	4	the	the	DET
dhrp-35	13	5	most	most	ADV
dhrp-35	13	6	impactful	impactful	ADJ
dhrp-35	13	7	in	in	ADP
dhrp-35	13	8	terms	term	NOUN
dhrp-35	13	9	of	of	ADP
dhrp-35	13	10	its	its	PRON
dhrp-35	13	11	transmissibility	transmissibility	NOUN
dhrp-35	13	12	and	and	CCONJ
dhrp-35	13	13	infectivity	infectivity	NOUN
dhrp-35	13	14	has	have	AUX
dhrp-35	13	15	been	be	AUX
dhrp-35	13	16	the	the	DET
dhrp-35	13	17	delta	delta	NOUN
dhrp-35	13	18	(	(	PUNCT
dhrp-35	13	19	b.1.617.2	b.1.617.2	PROPN
dhrp-35	13	20	)	)	PUNCT
dhrp-35	13	21	variant	variant	NOUN
dhrp-35	13	22	of	of	ADP
dhrp-35	13	23	sars	sar	NOUN
dhrp-35	13	24	-	-	PUNCT
dhrp-35	13	25	cov-2	cov-2	NOUN
dhrp-35	13	26	.	.	PUNCT
dhrp-35	14	1	first	first	ADV
dhrp-35	14	2	identified	identify	VERB
dhrp-35	14	3	in	in	ADP
dhrp-35	14	4	india	india	PROPN
dhrp-35	14	5	in	in	ADP
dhrp-35	14	6	december	december	PROPN
dhrp-35	14	7	2020	2020	NUM
dhrp-35	14	8	,	,	PUNCT
dhrp-35	14	9	the	the	DET
dhrp-35	14	10	delta	delta	NOUN
dhrp-35	14	11	variant	variant	NOUN
dhrp-35	14	12	swept	sweep	VERB
dhrp-35	14	13	rapidly	rapidly	ADV
dhrp-35	14	14	through	through	ADP
dhrp-35	14	15	that	that	DET
dhrp-35	14	16	country	country	NOUN
dhrp-35	14	17	and	and	CCONJ
dhrp-35	14	18	great	great	ADJ
dhrp-35	14	19	britain	britain	PROPN
dhrp-35	14	20	before	before	ADP
dhrp-35	14	21	reaching	reach	VERB
dhrp-35	14	22	the	the	DET
dhrp-35	14	23	u.s	u.s	PROPN
dhrp-35	14	24	.	.	PROPN
dhrp-35	14	25	,	,	PUNCT
dhrp-35	14	26	where	where	SCONJ
dhrp-35	14	27	it	it	PRON
dhrp-35	14	28	quickly	quickly	ADV
dhrp-35	14	29	surged	surge	VERB
dhrp-35	14	30	.	.	PUNCT
dhrp-35	15	1	it	it	PRON
dhrp-35	15	2	is	be	AUX
dhrp-35	15	3	now	now	ADV
dhrp-35	15	4	the	the	DET
dhrp-35	15	5	predominant	predominant	ADJ
dhrp-35	15	6	sars	sar	NOUN
dhrp-35	15	7	-	-	PUNCT
dhrp-35	15	8	cov-2	cov-2	NOUN
dhrp-35	15	9	variant	variant	NOUN
dhrp-35	15	10	,	,	PUNCT
dhrp-35	15	11	accounting	account	VERB
dhrp-35	15	12	for	for	ADP
dhrp-35	15	13	more	more	ADJ
dhrp-35	15	14	than	than	ADP
dhrp-35	15	15	99	99	NUM
dhrp-35	15	16	%	%	NOUN
dhrp-35	15	17	of	of	ADP
dhrp-35	15	18	covid-19	covid-19	PROPN
dhrp-35	15	19	cases	case	NOUN
dhrp-35	15	20	and	and	CCONJ
dhrp-35	15	21	leading	lead	VERB
dhrp-35	15	22	to	to	ADP
dhrp-35	15	23	an	an	DET
dhrp-35	15	24	overwhelming	overwhelming	ADJ
dhrp-35	15	25	increase	increase	NOUN
dhrp-35	15	26	in	in	ADP
dhrp-35	15	27	hospitalizations	hospitalization	NOUN
dhrp-35	15	28	in	in	ADP
dhrp-35	15	29	some	some	DET
dhrp-35	15	30	states	state	NOUN
dhrp-35	15	31	(	(	PUNCT
dhrp-35	15	32	2	2	NUM
dhrp-35	15	33	)	)	PUNCT
dhrp-35	15	34	.	.	PUNCT
dhrp-35	16	1	the	the	DET
dhrp-35	16	2	delta	delta	NOUN
dhrp-35	16	3	variant	variant	NOUN
dhrp-35	16	4	was	be	AUX
dhrp-35	16	5	believed	believe	VERB
dhrp-35	16	6	to	to	PART
dhrp-35	16	7	be	be	AUX
dhrp-35	16	8	more	more	ADJ
dhrp-35	16	9	than	than	ADP
dhrp-35	16	10	five	five	NUM
dhrp-35	16	11	times	time	NOUN
dhrp-35	16	12	as	as	ADV
dhrp-35	16	13	contagious	contagious	ADJ
dhrp-35	16	14	as	as	ADP
dhrp-35	16	15	previous	previous	ADJ
dhrp-35	16	16	variants	variant	NOUN
dhrp-35	16	17	,	,	PUNCT
dhrp-35	16	18	and	and	CCONJ
dhrp-35	16	19	studies	study	NOUN
dhrp-35	16	20	have	have	AUX
dhrp-35	16	21	shown	show	VERB
dhrp-35	16	22	that	that	SCONJ
dhrp-35	16	23	it	it	PRON
dhrp-35	16	24	may	may	AUX
dhrp-35	16	25	be	be	AUX
dhrp-35	16	26	more	more	ADV
dhrp-35	16	27	likely	likely	ADJ
dhrp-35	16	28	than	than	ADP
dhrp-35	16	29	the	the	DET
dhrp-35	16	30	original	original	ADJ
dhrp-35	16	31	virus	virus	NOUN
dhrp-35	16	32	to	to	PART
dhrp-35	16	33	put	put	VERB
dhrp-35	16	34	infected	infected	ADJ
dhrp-35	16	35	people	people	NOUN
dhrp-35	16	36	in	in	ADP
dhrp-35	16	37	the	the	DET
dhrp-35	16	38	hospital	hospital	NOUN
dhrp-35	16	39	.	.	PUNCT
dhrp-35	17	1	people	people	NOUN
dhrp-35	17	2	who	who	PRON
dhrp-35	17	3	are	be	AUX
dhrp-35	17	4	not	not	PART
dhrp-35	17	5	vaccinated	vaccinate	VERB
dhrp-35	17	6	are	be	AUX
dhrp-35	17	7	most	most	ADV
dhrp-35	17	8	at	at	ADP
dhrp-35	17	9	risk	risk	NOUN
dhrp-35	17	10	,	,	PUNCT
dhrp-35	17	11	and	and	CCONJ
dhrp-35	17	12	the	the	DET
dhrp-35	17	13	highest	high	ADJ
dhrp-35	17	14	spread	spread	NOUN
dhrp-35	17	15	of	of	ADP
dhrp-35	17	16	cases	case	NOUN
dhrp-35	17	17	and	and	CCONJ
dhrp-35	17	18	severe	severe	ADJ
dhrp-35	17	19	outcomes	outcome	NOUN
dhrp-35	17	20	is	be	AUX
dhrp-35	17	21	happening	happen	VERB
dhrp-35	17	22	in	in	ADP
dhrp-35	17	23	states	state	NOUN
dhrp-35	17	24	with	with	ADP
dhrp-35	17	25	low	low	ADJ
dhrp-35	17	26	vaccination	vaccination	NOUN
dhrp-35	17	27	rates	rate	NOUN
dhrp-35	17	28	.	.	PUNCT
dhrp-35	18	1	https://orcid.org/0000-0001-5027-9992	https://orcid.org/0000-0001-5027-9992	PROPN
dhrp-35	18	2	mailto:s.rao@dhr-rgv.com	mailto:s.rao@dhr-rgv.com	PROPN
dhrp-35	18	3	https://orcid.org/0000-0003-4146-3282	https://orcid.org/0000-0003-4146-3282	PROPN
dhrp-35	18	4	dhrp	dhrp	ADJ
dhrp-35	18	5	,	,	PUNCT
dhrp-35	18	6	2021	2021	NUM
dhrp-35	18	7	,	,	PUNCT
dhrp-35	18	8	vol	vol	NOUN
dhrp-35	18	9	.	.	NOUN
dhrp-35	18	10	1	1	NUM
dhrp-35	18	11	(	(	PUNCT
dhrp-35	18	12	s5	s5	NOUN
dhrp-35	18	13	)	)	PUNCT
dhrp-35	18	14	7	7	NUM
dhrp-35	18	15	-	-	SYM
dhrp-35	18	16	10	10	NUM
dhrp-35	18	17	the	the	DET
dhrp-35	18	18	b.1.1.529	b.1.1.529	ADJ
dhrp-35	18	19	(	(	PUNCT
dhrp-35	18	20	omicron	omicron	PROPN
dhrp-35	18	21	)	)	PUNCT
dhrp-35	18	22	variant	variant	NOUN
dhrp-35	18	23	of	of	ADP
dhrp-35	18	24	sars	sar	NOUN
dhrp-35	18	25	-	-	PUNCT
dhrp-35	18	26	cov-2	cov-2	NUM
dhrp-35	18	27	http://dhrproceedings.org	http://dhrproceedings.org	PROPN
dhrp-35	18	28	8	8	NUM
dhrp-35	18	29	©	©	PROPN
dhrp-35	18	30	dhr	dhr	PROPN
dhrp-35	18	31	health	health	PROPN
dhrp-35	18	32	institute	institute	PROPN
dhrp-35	18	33	for	for	ADP
dhrp-35	18	34	research	research	NOUN
dhrp-35	18	35	and	and	CCONJ
dhrp-35	18	36	development	development	NOUN
dhrp-35	18	37	table	table	NOUN
dhrp-35	18	38	1	1	NUM
dhrp-35	18	39	:	:	PUNCT
dhrp-35	18	40	us	us	PROPN
dhrp-35	18	41	government	government	NOUN
dhrp-35	18	42	sars	sar	NOUN
dhrp-35	18	43	-	-	PUNCT
dhrp-35	18	44	cov-2	cov-2	PART
dhrp-35	18	45	interagency	interagency	NOUN
dhrp-35	18	46	group	group	NOUN
dhrp-35	18	47	classification	classification	NOUN
dhrp-35	18	48	of	of	ADP
dhrp-35	18	49	sars	sar	NOUN
dhrp-35	18	50	-	-	PUNCT
dhrp-35	18	51	cov-2	cov-2	NOUN
dhrp-35	18	52	variants	variant	NOUN
dhrp-35	18	53	(	(	PUNCT
dhrp-35	18	54	as	as	ADP
dhrp-35	18	55	of	of	ADP
dhrp-35	18	56	november	november	PROPN
dhrp-35	18	57	26	26	NUM
dhrp-35	18	58	,	,	PUNCT
dhrp-35	18	59	2021	2021	NUM
dhrp-35	18	60	;	;	PUNCT
dhrp-35	18	61	1400	1400	NUM
dhrp-35	18	62	hrs	hrs	NOUN
dhrp-35	18	63	.	.	PUNCT
dhrp-35	18	64	)	)	PUNCT
dhrp-35	19	1	classification	classification	NOUN
dhrp-35	19	2	definition	definition	NOUN
dhrp-35	19	3	variants	variant	NOUN
dhrp-35	19	4	identified	identify	VERB
dhrp-35	19	5	variant	variant	NOUN
dhrp-35	19	6	being	be	AUX
dhrp-35	19	7	monitored	monitor	VERB
dhrp-35	19	8	(	(	PUNCT
dhrp-35	19	9	vbm	vbm	PROPN
dhrp-35	19	10	)	)	PUNCT
dhrp-35	19	11	variant	variant	NOUN
dhrp-35	19	12	for	for	ADP
dhrp-35	19	13	which	which	PRON
dhrp-35	19	14	there	there	PRON
dhrp-35	19	15	is	be	VERB
dhrp-35	19	16	data	datum	NOUN
dhrp-35	19	17	indicating	indicate	VERB
dhrp-35	19	18	a	a	DET
dhrp-35	19	19	potential	potential	ADJ
dhrp-35	19	20	or	or	CCONJ
dhrp-35	19	21	clear	clear	ADJ
dhrp-35	19	22	impact	impact	NOUN
dhrp-35	19	23	of	of	ADP
dhrp-35	19	24	approved	approve	VERB
dhrp-35	19	25	or	or	CCONJ
dhrp-35	19	26	authorized	authorize	VERB
dhrp-35	19	27	medical	medical	ADJ
dhrp-35	19	28	countermeasures	countermeasure	NOUN
dhrp-35	19	29	;	;	PUNCT
dhrp-35	19	30	or	or	CCONJ
dhrp-35	19	31	that	that	PRON
dhrp-35	19	32	has	have	AUX
dhrp-35	19	33	been	be	AUX
dhrp-35	19	34	associated	associate	VERB
dhrp-35	19	35	with	with	ADP
dhrp-35	19	36	more	more	ADV
dhrp-35	19	37	severe	severe	ADJ
dhrp-35	19	38	disease	disease	NOUN
dhrp-35	19	39	or	or	CCONJ
dhrp-35	19	40	increased	increase	VERB
dhrp-35	19	41	transmission	transmission	NOUN
dhrp-35	19	42	but	but	CCONJ
dhrp-35	19	43	are	be	AUX
dhrp-35	19	44	no	no	ADV
dhrp-35	19	45	longer	long	ADV
dhrp-35	19	46	detected	detect	VERB
dhrp-35	19	47	or	or	CCONJ
dhrp-35	19	48	are	be	AUX
dhrp-35	19	49	circulating	circulate	VERB
dhrp-35	19	50	at	at	ADP
dhrp-35	19	51	very	very	ADV
dhrp-35	19	52	low	low	ADJ
dhrp-35	19	53	levels	level	NOUN
dhrp-35	19	54	in	in	ADP
dhrp-35	19	55	the	the	DET
dhrp-35	19	56	united	united	PROPN
dhrp-35	19	57	states	states	PROPN
dhrp-35	19	58	,	,	PUNCT
dhrp-35	19	59	and	and	CCONJ
dhrp-35	19	60	as	as	ADP
dhrp-35	19	61	such	such	ADJ
dhrp-35	19	62	,	,	PUNCT
dhrp-35	19	63	do	do	AUX
dhrp-35	19	64	not	not	PART
dhrp-35	19	65	pose	pose	VERB
dhrp-35	19	66	a	a	DET
dhrp-35	19	67	significant	significant	ADJ
dhrp-35	19	68	and	and	CCONJ
dhrp-35	19	69	imminent	imminent	ADJ
dhrp-35	19	70	risk	risk	NOUN
dhrp-35	19	71	to	to	ADP
dhrp-35	19	72	public	public	ADJ
dhrp-35	19	73	health	health	NOUN
dhrp-35	19	74	in	in	ADP
dhrp-35	19	75	the	the	DET
dhrp-35	19	76	united	united	PROPN
dhrp-35	19	77	states	states	PROPN
dhrp-35	19	78	.	.	PUNCT
dhrp-35	20	1	•	•	NUM
dhrp-35	20	2	alpha	alpha	NOUN
dhrp-35	20	3	(	(	PUNCT
dhrp-35	20	4	b.1.1.7	b.1.1.7	VERB
dhrp-35	20	5	and	and	CCONJ
dhrp-35	20	6	q	q	ADJ
dhrp-35	20	7	lineages	lineage	NOUN
dhrp-35	20	8	)	)	PUNCT
dhrp-35	20	9	•	•	ADV
dhrp-35	20	10	beta	beta	NOUN
dhrp-35	20	11	(	(	PUNCT
dhrp-35	20	12	b.1.351	b.1.351	NOUN
dhrp-35	20	13	and	and	CCONJ
dhrp-35	20	14	descendent	descendent	NOUN
dhrp-35	20	15	lineages	lineage	NOUN
dhrp-35	20	16	)	)	PUNCT
dhrp-35	20	17	•	•	NOUN
dhrp-35	20	18	gamma	gamma	NOUN
dhrp-35	20	19	(	(	PUNCT
dhrp-35	20	20	p.1	p.1	NOUN
dhrp-35	20	21	and	and	CCONJ
dhrp-35	20	22	descendent	descendent	ADJ
dhrp-35	20	23	lineages	lineage	NOUN
dhrp-35	20	24	)	)	PUNCT
dhrp-35	20	25	•	•	NUM
dhrp-35	20	26	epsilon	epsilon	PROPN
dhrp-35	20	27	(	(	PUNCT
dhrp-35	20	28	b.1.427	b.1.427	NOUN
dhrp-35	20	29	and	and	CCONJ
dhrp-35	20	30	b.1.429	b.1.429	NOUN
dhrp-35	20	31	)	)	PUNCT
dhrp-35	20	32	•	•	NOUN
dhrp-35	21	1	eta	eta	INTJ
dhrp-35	21	2	(	(	PUNCT
dhrp-35	21	3	b.1.525	b.1.525	PROPN
dhrp-35	21	4	)	)	PUNCT
dhrp-35	21	5	•	•	NOUN
dhrp-35	21	6	iota	iota	NOUN
dhrp-35	21	7	(	(	PUNCT
dhrp-35	21	8	b.1.526	b.1.526	NOUN
dhrp-35	21	9	)	)	PUNCT
dhrp-35	21	10	•	•	NOUN
dhrp-35	21	11	kappa	kappa	PROPN
dhrp-35	21	12	(	(	PUNCT
dhrp-35	21	13	b.1.617.1	b.1.617.1	NOUN
dhrp-35	21	14	)	)	PUNCT
dhrp-35	21	15	•	•	NUM
dhrp-35	21	16	1.617.3	1.617.3	NUM
dhrp-35	21	17	•	•	NUM
dhrp-35	21	18	mu	mu	NOUN
dhrp-35	21	19	(	(	PUNCT
dhrp-35	21	20	b.1.621	b.1.621	PROPN
dhrp-35	21	21	,	,	PUNCT
dhrp-35	21	22	b.1.621.1	b.1.621.1	NOUN
dhrp-35	21	23	)	)	PUNCT
dhrp-35	21	24	•	•	NOUN
dhrp-35	21	25	zeta	zeta	NOUN
dhrp-35	21	26	(	(	PUNCT
dhrp-35	21	27	p.2	p.2	NOUN
dhrp-35	21	28	)	)	PUNCT
dhrp-35	21	29	variant	variant	NOUN
dhrp-35	21	30	of	of	ADP
dhrp-35	21	31	interest	interest	NOUN
dhrp-35	21	32	(	(	PUNCT
dhrp-35	21	33	voi	voi	NOUN
dhrp-35	21	34	)	)	PUNCT
dhrp-35	21	35	variant	variant	NOUN
dhrp-35	21	36	with	with	ADP
dhrp-35	21	37	specific	specific	ADJ
dhrp-35	21	38	genetic	genetic	ADJ
dhrp-35	21	39	markers	marker	NOUN
dhrp-35	21	40	that	that	PRON
dhrp-35	21	41	have	have	AUX
dhrp-35	21	42	been	be	AUX
dhrp-35	21	43	associated	associate	VERB
dhrp-35	21	44	with	with	ADP
dhrp-35	21	45	changes	change	NOUN
dhrp-35	21	46	to	to	ADP
dhrp-35	21	47	receptor	receptor	NOUN
dhrp-35	21	48	binding	bind	VERB
dhrp-35	21	49	;	;	PUNCT
dhrp-35	21	50	reduced	reduce	VERB
dhrp-35	21	51	neutralization	neutralization	NOUN
dhrp-35	21	52	by	by	ADP
dhrp-35	21	53	antibodies	antibody	NOUN
dhrp-35	21	54	generated	generate	VERB
dhrp-35	21	55	against	against	ADP
dhrp-35	21	56	previous	previous	ADJ
dhrp-35	21	57	infection	infection	NOUN
dhrp-35	21	58	or	or	CCONJ
dhrp-35	21	59	vaccination	vaccination	NOUN
dhrp-35	21	60	;	;	PUNCT
dhrp-35	21	61	reduced	reduce	VERB
dhrp-35	21	62	efficacy	efficacy	NOUN
dhrp-35	21	63	of	of	ADP
dhrp-35	21	64	treatments	treatment	NOUN
dhrp-35	21	65	;	;	PUNCT
dhrp-35	21	66	potential	potential	ADJ
dhrp-35	21	67	diagnostic	diagnostic	ADJ
dhrp-35	21	68	impact	impact	NOUN
dhrp-35	21	69	;	;	PUNCT
dhrp-35	21	70	or	or	CCONJ
dhrp-35	21	71	predicted	predict	VERB
dhrp-35	21	72	increase	increase	NOUN
dhrp-35	21	73	in	in	ADP
dhrp-35	21	74	transmissibility	transmissibility	NOUN
dhrp-35	21	75	or	or	CCONJ
dhrp-35	21	76	disease	disease	NOUN
dhrp-35	21	77	severity	severity	NOUN
dhrp-35	21	78	•	•	NOUN
dhrp-35	21	79	none	none	NOUN
dhrp-35	21	80	variant	variant	NOUN
dhrp-35	21	81	of	of	ADP
dhrp-35	21	82	concern	concern	NOUN
dhrp-35	21	83	(	(	PUNCT
dhrp-35	21	84	voc	voc	NOUN
dhrp-35	21	85	)	)	PUNCT
dhrp-35	21	86	variant	variant	NOUN
dhrp-35	21	87	for	for	ADP
dhrp-35	21	88	which	which	PRON
dhrp-35	21	89	there	there	PRON
dhrp-35	21	90	is	be	VERB
dhrp-35	21	91	evidence	evidence	NOUN
dhrp-35	21	92	of	of	ADP
dhrp-35	21	93	an	an	DET
dhrp-35	21	94	increase	increase	NOUN
dhrp-35	21	95	in	in	ADP
dhrp-35	21	96	transmissibility	transmissibility	NOUN
dhrp-35	21	97	;	;	PUNCT
dhrp-35	21	98	more	more	ADV
dhrp-35	21	99	severe	severe	ADJ
dhrp-35	21	100	disease	disease	NOUN
dhrp-35	21	101	(	(	PUNCT
dhrp-35	21	102	e.g.	e.g.	ADV
dhrp-35	21	103	,	,	PUNCT
dhrp-35	21	104	increased	increase	VERB
dhrp-35	21	105	hospitalizations	hospitalization	NOUN
dhrp-35	21	106	or	or	CCONJ
dhrp-35	21	107	deaths	death	NOUN
dhrp-35	21	108	)	)	PUNCT
dhrp-35	21	109	;	;	PUNCT
dhrp-35	21	110	significant	significant	ADJ
dhrp-35	21	111	reduction	reduction	NOUN
dhrp-35	21	112	in	in	ADP
dhrp-35	21	113	neutralization	neutralization	NOUN
dhrp-35	21	114	by	by	ADP
dhrp-35	21	115	antibodies	antibody	NOUN
dhrp-35	21	116	generated	generate	VERB
dhrp-35	21	117	during	during	ADP
dhrp-35	21	118	previous	previous	ADJ
dhrp-35	21	119	infection	infection	NOUN
dhrp-35	21	120	or	or	CCONJ
dhrp-35	21	121	vaccination	vaccination	NOUN
dhrp-35	21	122	;	;	PUNCT
dhrp-35	21	123	reduced	reduce	VERB
dhrp-35	21	124	effectiveness	effectiveness	NOUN
dhrp-35	21	125	of	of	ADP
dhrp-35	21	126	treatments	treatment	NOUN
dhrp-35	21	127	or	or	CCONJ
dhrp-35	21	128	vaccines	vaccine	NOUN
dhrp-35	21	129	;	;	PUNCT
dhrp-35	21	130	or	or	CCONJ
dhrp-35	21	131	diagnostic	diagnostic	ADJ
dhrp-35	21	132	detection	detection	NOUN
dhrp-35	21	133	failures	failure	NOUN
dhrp-35	21	134	•	•	NOUN
dhrp-35	21	135	delta	delta	NOUN
dhrp-35	21	136	(	(	PUNCT
dhrp-35	21	137	b.1.617.2	b.1.617.2	NOUN
dhrp-35	21	138	and	and	CCONJ
dhrp-35	21	139	ay	ay	NOUN
dhrp-35	21	140	lineages	lineage	NOUN
dhrp-35	21	141	)	)	PUNCT
dhrp-35	21	142	•	•	NUM
dhrp-35	21	143	omicron	omicron	PROPN
dhrp-35	21	144	(	(	PUNCT
dhrp-35	21	145	b.1.1.529	b.1.1.529	ADV
dhrp-35	21	146	)	)	PUNCT
dhrp-35	21	147	variant	variant	NOUN
dhrp-35	21	148	of	of	ADP
dhrp-35	21	149	high	high	ADJ
dhrp-35	21	150	consequence	consequence	NOUN
dhrp-35	21	151	(	(	PUNCT
dhrp-35	21	152	vohc	vohc	NOUN
dhrp-35	21	153	)	)	PUNCT
dhrp-35	21	154	variant	variant	NOUN
dhrp-35	21	155	of	of	ADP
dhrp-35	21	156	high	high	ADJ
dhrp-35	21	157	consequence	consequence	NOUN
dhrp-35	21	158	has	have	VERB
dhrp-35	21	159	clear	clear	ADJ
dhrp-35	21	160	evidence	evidence	NOUN
dhrp-35	21	161	that	that	SCONJ
dhrp-35	21	162	prevention	prevention	NOUN
dhrp-35	21	163	measures	measure	NOUN
dhrp-35	21	164	or	or	CCONJ
dhrp-35	21	165	medical	medical	ADJ
dhrp-35	21	166	countermeasures	countermeasure	NOUN
dhrp-35	21	167	(	(	PUNCT
dhrp-35	21	168	see	see	VERB
dhrp-35	21	169	below	below	ADV
dhrp-35	21	170	)	)	PUNCT
dhrp-35	21	171	have	have	AUX
dhrp-35	21	172	significantly	significantly	ADV
dhrp-35	21	173	reduced	reduce	VERB
dhrp-35	21	174	effectiveness	effectiveness	NOUN
dhrp-35	21	175	relative	relative	ADJ
dhrp-35	21	176	to	to	ADP
dhrp-35	21	177	previously	previously	ADV
dhrp-35	21	178	circulating	circulate	VERB
dhrp-35	21	179	variants	variant	NOUN
dhrp-35	21	180	.	.	PUNCT
dhrp-35	22	1	possible	possible	ADJ
dhrp-35	22	2	attributes	attribute	NOUN
dhrp-35	22	3	of	of	ADP
dhrp-35	22	4	a	a	DET
dhrp-35	22	5	variant	variant	NOUN
dhrp-35	22	6	of	of	ADP
dhrp-35	22	7	high	high	ADJ
dhrp-35	22	8	consequence	consequence	NOUN
dhrp-35	22	9	(	(	PUNCT
dhrp-35	22	10	in	in	ADP
dhrp-35	22	11	addition	addition	NOUN
dhrp-35	22	12	to	to	ADP
dhrp-35	22	13	the	the	DET
dhrp-35	22	14	possible	possible	ADJ
dhrp-35	22	15	attributes	attribute	NOUN
dhrp-35	22	16	of	of	ADP
dhrp-35	22	17	a	a	DET
dhrp-35	22	18	variant	variant	NOUN
dhrp-35	22	19	of	of	ADP
dhrp-35	22	20	concern	concern	NOUN
dhrp-35	22	21	):	):	PUNCT
dhrp-35	22	22	•	•	NUM
dhrp-35	22	23	demonstrated	demonstrate	VERB
dhrp-35	22	24	failure	failure	NOUN
dhrp-35	22	25	of	of	ADP
dhrp-35	22	26	diagnostic	diagnostic	ADJ
dhrp-35	22	27	test	test	NOUN
dhrp-35	22	28	targets	target	NOUN
dhrp-35	22	29	•	•	DET
dhrp-35	22	30	evidence	evidence	NOUN
dhrp-35	22	31	to	to	PART
dhrp-35	22	32	suggest	suggest	VERB
dhrp-35	22	33	a	a	DET
dhrp-35	22	34	significant	significant	ADJ
dhrp-35	22	35	reduction	reduction	NOUN
dhrp-35	22	36	in	in	ADP
dhrp-35	22	37	vaccine	vaccine	NOUN
dhrp-35	22	38	effectiveness	effectiveness	NOUN
dhrp-35	22	39	;	;	PUNCT
dhrp-35	22	40	a	a	DET
dhrp-35	22	41	disproportionately	disproportionately	ADV
dhrp-35	22	42	high	high	ADJ
dhrp-35	22	43	number	number	NOUN
dhrp-35	22	44	of	of	ADP
dhrp-35	22	45	infections	infection	NOUN
dhrp-35	22	46	in	in	ADP
dhrp-35	22	47	vaccinated	vaccinated	ADJ
dhrp-35	22	48	persons	person	NOUN
dhrp-35	22	49	;	;	PUNCT
dhrp-35	22	50	or	or	CCONJ
dhrp-35	22	51	very	very	ADV
dhrp-35	22	52	low	low	ADJ
dhrp-35	22	53	vaccineinduced	vaccineinduce	VERB
dhrp-35	22	54	protection	protection	NOUN
dhrp-35	22	55	against	against	ADP
dhrp-35	22	56	severe	severe	ADJ
dhrp-35	22	57	disease	disease	NOUN
dhrp-35	22	58	•	•	ADP
dhrp-35	22	59	significantly	significantly	ADV
dhrp-35	22	60	reduced	reduce	VERB
dhrp-35	22	61	susceptibility	susceptibility	NOUN
dhrp-35	22	62	to	to	ADP
dhrp-35	22	63	multiple	multiple	ADJ
dhrp-35	22	64	emergency	emergency	NOUN
dhrp-35	22	65	use	use	NOUN
dhrp-35	22	66	authorization	authorization	NOUN
dhrp-35	22	67	(	(	PUNCT
dhrp-35	22	68	eua	eua	PROPN
dhrp-35	22	69	)	)	PUNCT
dhrp-35	22	70	or	or	CCONJ
dhrp-35	22	71	approved	approve	VERB
dhrp-35	22	72	therapeutics	therapeutic	NOUN
dhrp-35	22	73	•	•	ADV
dhrp-35	22	74	more	more	ADV
dhrp-35	22	75	severe	severe	ADJ
dhrp-35	22	76	clinical	clinical	ADJ
dhrp-35	22	77	disease	disease	NOUN
dhrp-35	22	78	and	and	CCONJ
dhrp-35	22	79	increased	increase	VERB
dhrp-35	22	80	hospitalizations	hospitalization	NOUN
dhrp-35	22	81	•	•	ADV
dhrp-35	22	82	none	none	NOUN
dhrp-35	22	83	dhrp	dhrp	ADJ
dhrp-35	22	84	,	,	PUNCT
dhrp-35	22	85	2021	2021	NUM
dhrp-35	22	86	,	,	PUNCT
dhrp-35	22	87	vol	vol	NOUN
dhrp-35	22	88	.	.	NOUN
dhrp-35	22	89	1	1	NUM
dhrp-35	22	90	(	(	PUNCT
dhrp-35	22	91	s5	s5	NOUN
dhrp-35	22	92	)	)	PUNCT
dhrp-35	22	93	7	7	NUM
dhrp-35	22	94	-	-	SYM
dhrp-35	22	95	10	10	NUM
dhrp-35	22	96	the	the	DET
dhrp-35	22	97	b.1.1.529	b.1.1.529	ADJ
dhrp-35	22	98	(	(	PUNCT
dhrp-35	22	99	omicron	omicron	PROPN
dhrp-35	22	100	)	)	PUNCT
dhrp-35	22	101	variant	variant	NOUN
dhrp-35	22	102	of	of	ADP
dhrp-35	22	103	sars	sar	NOUN
dhrp-35	22	104	-	-	PUNCT
dhrp-35	22	105	cov-2	cov-2	NOUN
dhrp-35	22	106	http://dhrproceedings.org	http://dhrproceedings.org	PROPN
dhrp-35	22	107	9	9	NUM
dhrp-35	22	108	©	©	PROPN
dhrp-35	22	109	dhr	dhr	PROPN
dhrp-35	22	110	health	health	PROPN
dhrp-35	22	111	institute	institute	PROPN
dhrp-35	22	112	for	for	ADP
dhrp-35	22	113	research	research	NOUN
dhrp-35	22	114	and	and	CCONJ
dhrp-35	22	115	development	development	NOUN
dhrp-35	22	116	on	on	ADP
dhrp-35	22	117	november	november	PROPN
dhrp-35	22	118	13	13	NUM
dhrp-35	22	119	,	,	PUNCT
dhrp-35	22	120	2021	2021	NUM
dhrp-35	22	121	,	,	PUNCT
dhrp-35	22	122	thomas	thomas	PROPN
dhrp-35	22	123	peacock	peacock	PROPN
dhrp-35	22	124	,	,	PUNCT
dhrp-35	22	125	a	a	DET
dhrp-35	22	126	post	post	ADJ
dhrp-35	22	127	-	-	ADJ
dhrp-35	22	128	doctoral	doctoral	ADJ
dhrp-35	22	129	fellow	fellow	NOUN
dhrp-35	22	130	in	in	ADP
dhrp-35	22	131	the	the	DET
dhrp-35	22	132	division	division	NOUN
dhrp-35	22	133	of	of	ADP
dhrp-35	22	134	infectious	infectious	ADJ
dhrp-35	22	135	diseases	disease	NOUN
dhrp-35	22	136	,	,	PUNCT
dhrp-35	22	137	imperial	imperial	ADJ
dhrp-35	22	138	college	college	PROPN
dhrp-35	22	139	london	london	PROPN
dhrp-35	22	140	,	,	PUNCT
dhrp-35	22	141	london	london	PROPN
dhrp-35	22	142	,	,	PUNCT
dhrp-35	22	143	united	united	PROPN
dhrp-35	22	144	kingdom	kingdom	PROPN
dhrp-35	22	145	submitted	submit	VERB
dhrp-35	22	146	a	a	DET
dhrp-35	22	147	sequence	sequence	NOUN
dhrp-35	22	148	to	to	ADP
dhrp-35	22	149	github	github	NOUN
dhrp-35	22	150	of	of	ADP
dhrp-35	22	151	a	a	DET
dhrp-35	22	152	new	new	ADJ
dhrp-35	22	153	variant	variant	NOUN
dhrp-35	22	154	(	(	PUNCT
dhrp-35	22	155	b.1.1.529	b.1.1.529	ADV
dhrp-35	22	156	)	)	PUNCT
dhrp-35	22	157	of	of	ADP
dhrp-35	22	158	sars	sar	NOUN
dhrp-35	22	159	-	-	PUNCT
dhrp-35	22	160	cov-2	cov-2	NOUN
dhrp-35	22	161	isolated	isolate	VERB
dhrp-35	22	162	from	from	ADP
dhrp-35	22	163	an	an	DET
dhrp-35	22	164	immunocompromised	immunocompromise	VERB
dhrp-35	22	165	patient	patient	NOUN
dhrp-35	22	166	in	in	ADP
dhrp-35	22	167	south	south	PROPN
dhrp-35	22	168	africa	africa	PROPN
dhrp-35	22	169	(	(	PUNCT
dhrp-35	22	170	3	3	NUM
dhrp-35	22	171	)	)	PUNCT
dhrp-35	22	172	.	.	PUNCT
dhrp-35	23	1	according	accord	VERB
dhrp-35	23	2	to	to	ADP
dhrp-35	23	3	the	the	DET
dhrp-35	23	4	available	available	ADJ
dhrp-35	23	5	data	datum	NOUN
dhrp-35	23	6	,	,	PUNCT
dhrp-35	23	7	the	the	DET
dhrp-35	23	8	new	new	ADJ
dhrp-35	23	9	variant	variant	NOUN
dhrp-35	23	10	has	have	VERB
dhrp-35	23	11	32	32	NUM
dhrp-35	23	12	mutations	mutation	NOUN
dhrp-35	23	13	in	in	ADP
dhrp-35	23	14	the	the	DET
dhrp-35	23	15	conserved	conserved	ADJ
dhrp-35	23	16	domain	domain	NOUN
dhrp-35	23	17	of	of	ADP
dhrp-35	23	18	the	the	DET
dhrp-35	23	19	spike	spike	ADJ
dhrp-35	23	20	protein	protein	NOUN
dhrp-35	23	21	which	which	PRON
dhrp-35	23	22	,	,	PUNCT
dhrp-35	23	23	is	be	AUX
dhrp-35	23	24	the	the	DET
dhrp-35	23	25	region	region	NOUN
dhrp-35	23	26	of	of	ADP
dhrp-35	23	27	the	the	DET
dhrp-35	23	28	sars	sar	NOUN
dhrp-35	23	29	-	-	PUNCT
dhrp-35	23	30	cov-2	cov-2	NOUN
dhrp-35	23	31	that	that	PRON
dhrp-35	23	32	binds	bind	VERB
dhrp-35	23	33	to	to	ADP
dhrp-35	23	34	the	the	DET
dhrp-35	23	35	angiotensin	angiotensin	NOUN
dhrp-35	23	36	-	-	PUNCT
dhrp-35	23	37	converting	convert	VERB
dhrp-35	23	38	enzyme	enzyme	NOUN
dhrp-35	23	39	2	2	NUM
dhrp-35	23	40	(	(	PUNCT
dhrp-35	23	41	ace2	ace2	PROPN
dhrp-35	23	42	)	)	PUNCT
dhrp-35	23	43	allowing	allow	VERB
dhrp-35	23	44	for	for	ADP
dhrp-35	23	45	the	the	DET
dhrp-35	23	46	conformational	conformational	ADJ
dhrp-35	23	47	change	change	NOUN
dhrp-35	23	48	that	that	PRON
dhrp-35	23	49	facilitates	facilitate	VERB
dhrp-35	23	50	its	its	PRON
dhrp-35	23	51	entry	entry	NOUN
dhrp-35	23	52	into	into	ADP
dhrp-35	23	53	host	host	NOUN
dhrp-35	23	54	cells	cell	NOUN
dhrp-35	23	55	and	and	CCONJ
dhrp-35	23	56	is	be	AUX
dhrp-35	23	57	the	the	DET
dhrp-35	23	58	target	target	NOUN
dhrp-35	23	59	of	of	ADP
dhrp-35	23	60	immune	immune	ADJ
dhrp-35	23	61	responses	response	NOUN
dhrp-35	23	62	.	.	PUNCT
dhrp-35	24	1	additionally	additionally	ADV
dhrp-35	24	2	,	,	PUNCT
dhrp-35	24	3	19	19	NUM
dhrp-35	24	4	mutations	mutation	NOUN
dhrp-35	24	5	were	be	AUX
dhrp-35	24	6	also	also	ADV
dhrp-35	24	7	identified	identify	VERB
dhrp-35	24	8	in	in	ADP
dhrp-35	24	9	the	the	DET
dhrp-35	24	10	conserved	conserved	ADJ
dhrp-35	24	11	non	non	ADJ
dhrp-35	24	12	-	-	ADJ
dhrp-35	24	13	spike	spike	ADJ
dhrp-35	24	14	region	region	NOUN
dhrp-35	24	15	of	of	ADP
dhrp-35	24	16	the	the	DET
dhrp-35	24	17	b.1.1.529	b.1.1.529	ADJ
dhrp-35	24	18	variant	variant	NOUN
dhrp-35	24	19	which	which	PRON
dhrp-35	24	20	,	,	PUNCT
dhrp-35	24	21	are	be	AUX
dhrp-35	24	22	assumed	assume	VERB
dhrp-35	24	23	to	to	PART
dhrp-35	24	24	be	be	AUX
dhrp-35	24	25	of	of	ADP
dhrp-35	24	26	less	less	ADJ
dhrp-35	24	27	significance	significance	NOUN
dhrp-35	24	28	in	in	ADP
dhrp-35	24	29	terms	term	NOUN
dhrp-35	24	30	of	of	ADP
dhrp-35	24	31	the	the	DET
dhrp-35	24	32	transmissibility	transmissibility	NOUN
dhrp-35	24	33	and	and	CCONJ
dhrp-35	24	34	infectivity	infectivity	NOUN
dhrp-35	24	35	of	of	ADP
dhrp-35	24	36	the	the	DET
dhrp-35	24	37	sars	sar	NOUN
dhrp-35	24	38	-	-	PUNCT
dhrp-35	24	39	cov-2	cov-2	NOUN
dhrp-35	24	40	.	.	PUNCT
dhrp-35	25	1	while	while	SCONJ
dhrp-35	25	2	most	most	ADJ
dhrp-35	25	3	of	of	ADP
dhrp-35	25	4	the	the	DET
dhrp-35	25	5	mutations	mutation	NOUN
dhrp-35	25	6	in	in	ADP
dhrp-35	25	7	the	the	DET
dhrp-35	25	8	spike	spike	ADJ
dhrp-35	25	9	region	region	NOUN
dhrp-35	25	10	of	of	ADP
dhrp-35	25	11	b.1.1.529	b.1.1.529	ADV
dhrp-35	25	12	were	be	AUX
dhrp-35	25	13	similar	similar	ADJ
dhrp-35	25	14	to	to	ADP
dhrp-35	25	15	that	that	PRON
dhrp-35	25	16	in	in	ADP
dhrp-35	25	17	the	the	DET
dhrp-35	25	18	delta	delta	NOUN
dhrp-35	25	19	variant	variant	NOUN
dhrp-35	25	20	,	,	PUNCT
dhrp-35	25	21	some	some	PRON
dhrp-35	25	22	were	be	AUX
dhrp-35	25	23	unique	unique	ADJ
dhrp-35	25	24	which	which	PRON
dhrp-35	25	25	raised	raise	VERB
dhrp-35	25	26	serious	serious	ADJ
dhrp-35	25	27	concerns	concern	NOUN
dhrp-35	25	28	about	about	ADP
dhrp-35	25	29	the	the	DET
dhrp-35	25	30	transmissibility	transmissibility	NOUN
dhrp-35	25	31	of	of	ADP
dhrp-35	25	32	this	this	DET
dhrp-35	25	33	variant	variant	NOUN
dhrp-35	25	34	.	.	PUNCT
dhrp-35	26	1	in	in	ADP
dhrp-35	26	2	fact	fact	NOUN
dhrp-35	26	3	,	,	PUNCT
dhrp-35	26	4	the	the	DET
dhrp-35	26	5	b.1.1.529	b.1.1.529	NOUN
dhrp-35	26	6	is	be	AUX
dhrp-35	26	7	now	now	ADV
dhrp-35	26	8	the	the	DET
dhrp-35	26	9	most	most	ADV
dhrp-35	26	10	dominant	dominant	ADJ
dhrp-35	26	11	variant	variant	NOUN
dhrp-35	26	12	identified	identify	VERB
dhrp-35	26	13	in	in	ADP
dhrp-35	26	14	patients	patient	NOUN
dhrp-35	26	15	with	with	ADP
dhrp-35	26	16	covid-19	covid-19	PROPN
dhrp-35	26	17	in	in	ADP
dhrp-35	26	18	south	south	PROPN
dhrp-35	26	19	africa	africa	PROPN
dhrp-35	26	20	and	and	CCONJ
dhrp-35	26	21	has	have	AUX
dhrp-35	26	22	already	already	ADV
dhrp-35	26	23	been	be	AUX
dhrp-35	26	24	isolated	isolate	VERB
dhrp-35	26	25	from	from	ADP
dhrp-35	26	26	patients	patient	NOUN
dhrp-35	26	27	with	with	ADP
dhrp-35	26	28	covid-19	covid-19	PROPN
dhrp-35	26	29	in	in	ADP
dhrp-35	26	30	other	other	ADJ
dhrp-35	26	31	southern	southern	ADJ
dhrp-35	26	32	african	african	ADJ
dhrp-35	26	33	countries	country	NOUN
dhrp-35	26	34	(	(	PUNCT
dhrp-35	26	35	lesotho	lesotho	PROPN
dhrp-35	26	36	,	,	PUNCT
dhrp-35	26	37	botswana	botswana	PROPN
dhrp-35	26	38	,	,	PUNCT
dhrp-35	26	39	namibia	namibia	PROPN
dhrp-35	26	40	,	,	PUNCT
dhrp-35	26	41	eswatini	eswatini	NOUN
dhrp-35	26	42	and	and	CCONJ
dhrp-35	26	43	zimbabwe	zimbabwe	ADJ
dhrp-35	26	44	)	)	PUNCT
dhrp-35	26	45	,	,	PUNCT
dhrp-35	26	46	belgium	belgium	PROPN
dhrp-35	26	47	,	,	PUNCT
dhrp-35	26	48	israel	israel	PROPN
dhrp-35	26	49	,	,	PUNCT
dhrp-35	26	50	and	and	CCONJ
dhrp-35	26	51	hong	hong	PROPN
dhrp-35	26	52	kong	kong	PROPN
dhrp-35	26	53	(	(	PUNCT
dhrp-35	26	54	5	5	NUM
dhrp-35	26	55	)	)	PUNCT
dhrp-35	26	56	.	.	PUNCT
dhrp-35	27	1	according	accord	VERB
dhrp-35	27	2	to	to	ADP
dhrp-35	27	3	the	the	DET
dhrp-35	27	4	modelling	modelling	NOUN
dhrp-35	27	5	using	use	VERB
dhrp-35	27	6	s	s	PART
dhrp-35	27	7	-	-	PUNCT
dhrp-35	27	8	gene	gene	NOUN
dhrp-35	27	9	target	target	NOUN
dhrp-35	27	10	failure	failure	NOUN
dhrp-35	27	11	(	(	PUNCT
dhrp-35	27	12	sdft	sdft	ADJ
dhrp-35	27	13	)	)	PUNCT
dhrp-35	27	14	data	datum	NOUN
dhrp-35	27	15	,	,	PUNCT
dhrp-35	27	16	the	the	DET
dhrp-35	27	17	rate	rate	NOUN
dhrp-35	27	18	of	of	ADP
dhrp-35	27	19	infection	infection	NOUN
dhrp-35	27	20	from	from	ADP
dhrp-35	27	21	the	the	DET
dhrp-35	27	22	b.1.1.529	b.1.1.529	NOUN
dhrp-35	27	23	will	will	AUX
dhrp-35	27	24	be	be	AUX
dhrp-35	27	25	100	100	NUM
dhrp-35	27	26	-	-	NUM
dhrp-35	27	27	fold	fold	VERB
dhrp-35	27	28	higher	high	ADJ
dhrp-35	27	29	as	as	ADP
dhrp-35	27	30	compared	compare	VERB
dhrp-35	27	31	to	to	ADP
dhrp-35	27	32	that	that	PRON
dhrp-35	27	33	to	to	ADP
dhrp-35	27	34	the	the	DET
dhrp-35	27	35	delta	delta	NOUN
dhrp-35	27	36	variant	variant	NOUN
dhrp-35	27	37	of	of	ADP
dhrp-35	27	38	sars	sar	NOUN
dhrp-35	27	39	-	-	PUNCT
dhrp-35	27	40	cov-2	cov-2	PART
dhrp-35	27	41	(	(	PUNCT
dhrp-35	27	42	figure	figure	NOUN
dhrp-35	27	43	1	1	NUM
dhrp-35	27	44	)	)	PUNCT
dhrp-35	27	45	.	.	PUNCT
dhrp-35	28	1	figure	figure	VERB
dhrp-35	28	2	1	1	NUM
dhrp-35	28	3	:	:	PUNCT
dhrp-35	28	4	modeling	modeling	NOUN
dhrp-35	28	5	of	of	ADP
dhrp-35	28	6	spread	spread	NOUN
dhrp-35	28	7	of	of	ADP
dhrp-35	28	8	covid-19	covid-19	PROPN
dhrp-35	28	9	cases	case	NOUN
dhrp-35	28	10	in	in	ADP
dhrp-35	28	11	south	south	PROPN
dhrp-35	28	12	africa	africa	PROPN
dhrp-35	28	13	from	from	ADP
dhrp-35	28	14	infection	infection	NOUN
dhrp-35	28	15	with	with	ADP
dhrp-35	28	16	b.1.1.529	b.1.1.529	ADV
dhrp-35	28	17	variant	variant	NOUN
dhrp-35	28	18	of	of	ADP
dhrp-35	28	19	sars	sar	NOUN
dhrp-35	28	20	-	-	PUNCT
dhrp-35	28	21	cov-2	cov-2	PART
dhrp-35	28	22	using	use	VERB
dhrp-35	28	23	s	s	PART
dhrp-35	28	24	-	-	PUNCT
dhrp-35	28	25	gene	gene	NOUN
dhrp-35	28	26	target	target	NOUN
dhrp-35	28	27	failure	failure	NOUN
dhrp-35	28	28	data	datum	NOUN
dhrp-35	28	29	*	*	PUNCT
dhrp-35	28	30	*	*	PUNCT
dhrp-35	28	31	source	source	NOUN
dhrp-35	28	32	:	:	PUNCT
dhrp-35	28	33	financial	financial	ADJ
dhrp-35	28	34	times	time	NOUN
dhrp-35	28	35	analysis	analysis	NOUN
dhrp-35	28	36	of	of	ADP
dhrp-35	28	37	data	datum	NOUN
dhrp-35	28	38	from	from	ADP
dhrp-35	28	39	global	global	ADJ
dhrp-35	28	40	initiative	initiative	NOUN
dhrp-35	28	41	on	on	ADP
dhrp-35	28	42	sharing	share	VERB
dhrp-35	28	43	avian	avian	ADJ
dhrp-35	28	44	influenza	influenza	NOUN
dhrp-35	28	45	data	datum	NOUN
dhrp-35	28	46	(	(	PUNCT
dhrp-35	28	47	gisaid	gisaid	NOUN
dhrp-35	28	48	)	)	PUNCT
dhrp-35	28	49	and	and	CCONJ
dhrp-35	28	50	the	the	DET
dhrp-35	28	51	south	south	ADJ
dhrp-35	28	52	african	african	ADJ
dhrp-35	28	53	national	national	PROPN
dhrp-35	28	54	health	health	PROPN
dhrp-35	28	55	laboratory	laboratory	PROPN
dhrp-35	28	56	service	service	NOUN
dhrp-35	28	57	given	give	VERB
dhrp-35	28	58	these	these	DET
dhrp-35	28	59	alarming	alarming	ADJ
dhrp-35	28	60	observations	observation	NOUN
dhrp-35	28	61	,	,	PUNCT
dhrp-35	28	62	the	the	DET
dhrp-35	28	63	technical	technical	ADJ
dhrp-35	28	64	advisory	advisory	ADJ
dhrp-35	28	65	group	group	NOUN
dhrp-35	28	66	of	of	ADP
dhrp-35	28	67	the	the	DET
dhrp-35	28	68	world	world	PROPN
dhrp-35	28	69	health	health	NOUN
dhrp-35	28	70	organization	organization	NOUN
dhrp-35	28	71	(	(	PUNCT
dhrp-35	28	72	who	who	PRON
dhrp-35	28	73	)	)	PUNCT
dhrp-35	28	74	met	meet	VERB
dhrp-35	28	75	on	on	ADP
dhrp-35	28	76	november	november	PROPN
dhrp-35	28	77	26	26	NUM
dhrp-35	28	78	,	,	PUNCT
dhrp-35	28	79	2021	2021	NUM
dhrp-35	28	80	,	,	PUNCT
dhrp-35	28	81	and	and	CCONJ
dhrp-35	28	82	classified	classify	VERB
dhrp-35	28	83	the	the	DET
dhrp-35	28	84	b.1.1.529	b.1.1.529	ADV
dhrp-35	28	85	as	as	ADP
dhrp-35	28	86	the	the	DET
dhrp-35	28	87	variant	variant	NOUN
dhrp-35	28	88	of	of	ADP
dhrp-35	28	89	concern	concern	NOUN
dhrp-35	28	90	and	and	CCONJ
dhrp-35	28	91	named	name	VERB
dhrp-35	28	92	it	it	PRON
dhrp-35	28	93	“	"	PUNCT
dhrp-35	28	94	omicron	omicron	PROPN
dhrp-35	28	95	”	"	PUNCT
dhrp-35	28	96	(	(	PUNCT
dhrp-35	28	97	6	6	NUM
dhrp-35	28	98	)	)	PUNCT
dhrp-35	28	99	.	.	PUNCT
dhrp-35	29	1	it	it	PRON
dhrp-35	29	2	is	be	AUX
dhrp-35	29	3	also	also	ADV
dhrp-35	29	4	unclear	unclear	ADJ
dhrp-35	29	5	at	at	ADP
dhrp-35	29	6	this	this	DET
dhrp-35	29	7	moment	moment	NOUN
dhrp-35	29	8	if	if	SCONJ
dhrp-35	29	9	the	the	DET
dhrp-35	29	10	immunity	immunity	NOUN
dhrp-35	29	11	acquired	acquire	VERB
dhrp-35	29	12	against	against	ADP
dhrp-35	29	13	sars	sar	NOUN
dhrp-35	29	14	-	-	PUNCT
dhrp-35	29	15	cov-2	cov-2	PART
dhrp-35	29	16	following	follow	VERB
dhrp-35	29	17	natural	natural	ADJ
dhrp-35	29	18	infection	infection	NOUN
dhrp-35	29	19	and/or	and/or	CCONJ
dhrp-35	29	20	vaccination	vaccination	NOUN
dhrp-35	29	21	would	would	AUX
dhrp-35	29	22	be	be	AUX
dhrp-35	29	23	effective	effective	ADJ
dhrp-35	29	24	against	against	ADP
dhrp-35	29	25	this	this	DET
dhrp-35	29	26	variant	variant	NOUN
dhrp-35	29	27	.	.	PUNCT
dhrp-35	30	1	equally	equally	ADV
dhrp-35	30	2	,	,	PUNCT
dhrp-35	30	3	disconcerting	disconcert	VERB
dhrp-35	30	4	is	be	AUX
dhrp-35	30	5	the	the	DET
dhrp-35	30	6	possibility	possibility	NOUN
dhrp-35	30	7	that	that	SCONJ
dhrp-35	30	8	the	the	DET
dhrp-35	30	9	existing	exist	VERB
dhrp-35	30	10	molecular	molecular	ADJ
dhrp-35	30	11	tests	test	NOUN
dhrp-35	30	12	that	that	PRON
dhrp-35	30	13	are	be	AUX
dhrp-35	30	14	commonly	commonly	ADV
dhrp-35	30	15	used	use	VERB
dhrp-35	30	16	to	to	PART
dhrp-35	30	17	diagnose	diagnose	VERB
dhrp-35	30	18	infection	infection	NOUN
dhrp-35	30	19	with	with	ADP
dhrp-35	30	20	sars	sar	NOUN
dhrp-35	30	21	-	-	PUNCT
dhrp-35	30	22	cov-2	cov-2	NOUN
dhrp-35	30	23	might	might	AUX
dhrp-35	30	24	be	be	AUX
dhrp-35	30	25	less	less	ADV
dhrp-35	30	26	effective	effective	ADJ
dhrp-35	30	27	in	in	ADP
dhrp-35	30	28	identifying	identify	VERB
dhrp-35	30	29	the	the	DET
dhrp-35	30	30	b.1.1.529	b.1.1.529	ADJ
dhrp-35	30	31	variant	variant	NOUN
dhrp-35	30	32	.	.	PUNCT
dhrp-35	31	1	nevertheless	nevertheless	ADV
dhrp-35	31	2	,	,	PUNCT
dhrp-35	31	3	to	to	PART
dhrp-35	31	4	contain	contain	VERB
dhrp-35	31	5	the	the	DET
dhrp-35	31	6	spread	spread	NOUN
dhrp-35	31	7	of	of	ADP
dhrp-35	31	8	omicron	omicron	PROPN
dhrp-35	31	9	,	,	PUNCT
dhrp-35	31	10	united	united	PROPN
dhrp-35	31	11	states	states	PROPN
dhrp-35	31	12	has	have	AUX
dhrp-35	31	13	banned	ban	VERB
dhrp-35	31	14	flights	flight	NOUN
dhrp-35	31	15	from	from	ADP
dhrp-35	31	16	seven	seven	NUM
dhrp-35	31	17	high	high	ADJ
dhrp-35	31	18	-	-	PUNCT
dhrp-35	31	19	risk	risk	NOUN
dhrp-35	31	20	countries	country	NOUN
dhrp-35	31	21	effective	effective	ADJ
dhrp-35	31	22	monday	monday	PROPN
dhrp-35	31	23	,	,	PUNCT
dhrp-35	31	24	november	november	PROPN
dhrp-35	31	25	29	29	NUM
dhrp-35	31	26	,	,	PUNCT
dhrp-35	31	27	2021	2021	NUM
dhrp-35	31	28	(	(	PUNCT
dhrp-35	31	29	7	7	NUM
dhrp-35	31	30	)	)	PUNCT
dhrp-35	31	31	.	.	PUNCT
dhrp-35	32	1	similar	similar	ADJ
dhrp-35	32	2	travel	travel	NOUN
dhrp-35	32	3	restrictions	restriction	NOUN
dhrp-35	32	4	have	have	AUX
dhrp-35	32	5	also	also	ADV
dhrp-35	32	6	been	be	AUX
dhrp-35	32	7	implemented	implement	VERB
dhrp-35	32	8	by	by	ADP
dhrp-35	32	9	many	many	ADJ
dhrp-35	32	10	other	other	ADJ
dhrp-35	32	11	countries	country	NOUN
dhrp-35	32	12	around	around	ADP
dhrp-35	32	13	the	the	DET
dhrp-35	32	14	globe	globe	NOUN
dhrp-35	32	15	.	.	PUNCT
dhrp-35	33	1	in	in	ADP
dhrp-35	33	2	conclusion	conclusion	NOUN
dhrp-35	33	3	,	,	PUNCT
dhrp-35	33	4	the	the	DET
dhrp-35	33	5	identification	identification	NOUN
dhrp-35	33	6	of	of	ADP
dhrp-35	33	7	a	a	DET
dhrp-35	33	8	new	new	ADJ
dhrp-35	33	9	potentially	potentially	ADV
dhrp-35	33	10	more	more	ADV
dhrp-35	33	11	dangerous	dangerous	ADJ
dhrp-35	33	12	variant	variant	NOUN
dhrp-35	33	13	is	be	AUX
dhrp-35	33	14	a	a	DET
dhrp-35	33	15	somber	somber	ADJ
dhrp-35	33	16	reminder	reminder	NOUN
dhrp-35	33	17	that	that	SCONJ
dhrp-35	33	18	the	the	DET
dhrp-35	33	19	world	world	NOUN
dhrp-35	33	20	is	be	AUX
dhrp-35	33	21	still	still	ADV
dhrp-35	33	22	living	live	VERB
dhrp-35	33	23	under	under	ADP
dhrp-35	33	24	the	the	DET
dhrp-35	33	25	umbrella	umbrella	NOUN
dhrp-35	33	26	of	of	ADP
dhrp-35	33	27	a	a	DET
dhrp-35	33	28	pandemic	pandemic	ADJ
dhrp-35	33	29	and	and	CCONJ
dhrp-35	33	30	remains	remain	VERB
dhrp-35	33	31	highly	highly	ADV
dhrp-35	33	32	vulnerable	vulnerable	ADJ
dhrp-35	33	33	to	to	ADP
dhrp-35	33	34	another	another	DET
dhrp-35	33	35	wave	wave	NOUN
dhrp-35	33	36	of	of	ADP
dhrp-35	33	37	sars	sar	NOUN
dhrp-35	33	38	-	-	PUNCT
dhrp-35	33	39	cov-2	cov-2	PART
dhrp-35	33	40	infection	infection	NOUN
dhrp-35	33	41	.	.	PUNCT
dhrp-35	34	1	despite	despite	SCONJ
dhrp-35	34	2	these	these	DET
dhrp-35	34	3	travel	travel	NOUN
dhrp-35	34	4	restrictions	restriction	NOUN
dhrp-35	34	5	,	,	PUNCT
dhrp-35	34	6	it	it	PRON
dhrp-35	34	7	is	be	AUX
dhrp-35	34	8	only	only	ADV
dhrp-35	34	9	a	a	DET
dhrp-35	34	10	matter	matter	NOUN
dhrp-35	34	11	of	of	ADP
dhrp-35	34	12	time	time	NOUN
dhrp-35	34	13	that	that	PRON
dhrp-35	34	14	the	the	DET
dhrp-35	34	15	b.1.1.529	b.1.1.529	ADJ
dhrp-35	34	16	variant	variant	NOUN
dhrp-35	34	17	will	will	AUX
dhrp-35	34	18	be	be	AUX
dhrp-35	34	19	identified	identify	VERB
dhrp-35	34	20	in	in	ADP
dhrp-35	34	21	patients	patient	NOUN
dhrp-35	34	22	in	in	ADP
dhrp-35	34	23	the	the	DET
dhrp-35	34	24	us	us	PROPN
dhrp-35	34	25	.	.	PUNCT
dhrp-35	35	1	in	in	ADP
dhrp-35	35	2	fact	fact	NOUN
dhrp-35	35	3	,	,	PUNCT
dhrp-35	35	4	we	we	PRON
dhrp-35	35	5	predict	predict	VERB
dhrp-35	35	6	that	that	SCONJ
dhrp-35	35	7	the	the	DET
dhrp-35	35	8	b.1.1.529	b.1.1.529	ADJ
dhrp-35	35	9	variant	variant	NOUN
dhrp-35	35	10	has	have	AUX
dhrp-35	35	11	already	already	ADV
dhrp-35	35	12	penetrated	penetrate	VERB
dhrp-35	35	13	the	the	DET
dhrp-35	35	14	us	us	PROPN
dhrp-35	35	15	eco	eco	NOUN
dhrp-35	35	16	-	-	PUNCT
dhrp-35	35	17	system	system	NOUN
dhrp-35	35	18	.	.	PUNCT
dhrp-35	36	1	while	while	SCONJ
dhrp-35	36	2	it	it	PRON
dhrp-35	36	3	must	must	AUX
dhrp-35	36	4	be	be	AUX
dhrp-35	36	5	confirmed	confirm	VERB
dhrp-35	36	6	unequivocally	unequivocally	ADV
dhrp-35	36	7	,	,	PUNCT
dhrp-35	36	8	given	give	VERB
dhrp-35	36	9	some	some	DET
dhrp-35	36	10	similarities	similarity	NOUN
dhrp-35	36	11	of	of	ADP
dhrp-35	36	12	observed	observed	ADJ
dhrp-35	36	13	mutations	mutation	NOUN
dhrp-35	36	14	in	in	ADP
dhrp-35	36	15	b.1.1.529	b.1.1.529	ADV
dhrp-35	36	16	to	to	ADP
dhrp-35	36	17	that	that	PRON
dhrp-35	36	18	to	to	ADP
dhrp-35	36	19	the	the	DET
dhrp-35	36	20	delta	delta	NOUN
dhrp-35	36	21	variant	variant	NOUN
dhrp-35	36	22	,	,	PUNCT
dhrp-35	36	23	we	we	PRON
dhrp-35	36	24	envisage	envisage	VERB
dhrp-35	36	25	that	that	SCONJ
dhrp-35	36	26	the	the	DET
dhrp-35	36	27	immune	immune	ADJ
dhrp-35	36	28	responses	response	NOUN
dhrp-35	36	29	raised	raise	VERB
dhrp-35	36	30	by	by	ADP
dhrp-35	36	31	the	the	DET
dhrp-35	36	32	currently	currently	ADV
dhrp-35	36	33	available	available	ADJ
dhrp-35	36	34	vaccines	vaccine	NOUN
dhrp-35	36	35	will	will	AUX
dhrp-35	36	36	be	be	AUX
dhrp-35	36	37	effective	effective	ADJ
dhrp-35	36	38	in	in	ADP
dhrp-35	36	39	protecting	protect	VERB
dhrp-35	36	40	against	against	ADP
dhrp-35	36	41	this	this	DET
dhrp-35	36	42	variant	variant	NOUN
dhrp-35	36	43	.	.	PUNCT
dhrp-35	37	1	it	it	PRON
dhrp-35	37	2	is	be	AUX
dhrp-35	37	3	the	the	DET
dhrp-35	37	4	degree	degree	NOUN
dhrp-35	37	5	of	of	ADP
dhrp-35	37	6	protection	protection	NOUN
dhrp-35	37	7	afforded	afford	VERB
dhrp-35	37	8	by	by	ADP
dhrp-35	37	9	these	these	DET
dhrp-35	37	10	vaccines	vaccine	NOUN
dhrp-35	37	11	against	against	ADP
dhrp-35	37	12	omicron	omicron	PROPN
dhrp-35	37	13	which	which	PRON
dhrp-35	37	14	is	be	AUX
dhrp-35	37	15	the	the	DET
dhrp-35	37	16	focus	focus	NOUN
dhrp-35	37	17	of	of	ADP
dhrp-35	37	18	studies	study	NOUN
dhrp-35	37	19	currently	currently	ADV
dhrp-35	37	20	underway	underway	ADJ
dhrp-35	37	21	.	.	PUNCT
dhrp-35	38	1	hence	hence	ADV
dhrp-35	38	2	the	the	DET
dhrp-35	38	3	need	need	NOUN
dhrp-35	38	4	for	for	ADP
dhrp-35	38	5	universal	universal	ADJ
dhrp-35	38	6	vaccination	vaccination	NOUN
dhrp-35	38	7	all	all	ADV
dhrp-35	38	8	around	around	ADP
dhrp-35	38	9	the	the	DET
dhrp-35	38	10	world	world	NOUN
dhrp-35	38	11	otherwise	otherwise	ADV
dhrp-35	38	12	,	,	PUNCT
dhrp-35	38	13	the	the	DET
dhrp-35	38	14	threat	threat	NOUN
dhrp-35	38	15	of	of	ADP
dhrp-35	38	16	evolving	evolve	VERB
dhrp-35	38	17	new	new	ADJ
dhrp-35	38	18	and	and	CCONJ
dhrp-35	38	19	more	more	ADV
dhrp-35	38	20	dangerous	dangerous	ADJ
dhrp-35	38	21	sars	sar	NOUN
dhrp-35	38	22	-	-	PUNCT
dhrp-35	38	23	cov-2	cov-2	PART
dhrp-35	38	24	variants	variant	NOUN
dhrp-35	38	25	will	will	AUX
dhrp-35	38	26	always	always	ADV
dhrp-35	38	27	be	be	AUX
dhrp-35	38	28	lurking	lurk	VERB
dhrp-35	38	29	in	in	ADP
dhrp-35	38	30	the	the	DET
dhrp-35	38	31	background	background	NOUN
dhrp-35	38	32	.	.	PUNCT
dhrp-35	39	1	recent	recent	ADJ
dhrp-35	39	2	affirmative	affirmative	ADJ
dhrp-35	39	3	news	news	NOUN
dhrp-35	39	4	about	about	ADP
dhrp-35	39	5	the	the	DET
dhrp-35	39	6	gradual	gradual	ADJ
dhrp-35	39	7	decline	decline	NOUN
dhrp-35	39	8	in	in	ADP
dhrp-35	39	9	the	the	DET
dhrp-35	39	10	rate	rate	NOUN
dhrp-35	39	11	of	of	ADP
dhrp-35	39	12	infection	infection	NOUN
dhrp-35	39	13	and	and	CCONJ
dhrp-35	39	14	hospitalization	hospitalization	NOUN
dhrp-35	39	15	in	in	ADP
dhrp-35	39	16	some	some	DET
dhrp-35	39	17	states	state	NOUN
dhrp-35	39	18	has	have	AUX
dhrp-35	39	19	perhaps	perhaps	ADV
dhrp-35	39	20	bestowed	bestow	VERB
dhrp-35	39	21	false	false	ADJ
dhrp-35	39	22	reassurance	reassurance	NOUN
dhrp-35	39	23	prompting	prompt	VERB
dhrp-35	39	24	many	many	ADJ
dhrp-35	39	25	to	to	PART
dhrp-35	39	26	abandon	abandon	VERB
dhrp-35	39	27	us	we	PRON
dhrp-35	39	28	centers	center	NOUN
dhrp-35	39	29	for	for	ADP
dhrp-35	39	30	disease	disease	NOUN
dhrp-35	39	31	control	control	PROPN
dhrp-35	39	32	&	&	CCONJ
dhrp-35	39	33	prevention	prevention	NOUN
dhrp-35	39	34	guidelines	guideline	NOUN
dhrp-35	39	35	for	for	ADP
dhrp-35	39	36	limiting	limit	VERB
dhrp-35	39	37	the	the	DET
dhrp-35	39	38	spread	spread	NOUN
dhrp-35	39	39	of	of	ADP
dhrp-35	39	40	covid-19	covid-19	PROPN
dhrp-35	39	41	.	.	PUNCT
dhrp-35	40	1	it	it	PRON
dhrp-35	40	2	is	be	AUX
dhrp-35	40	3	,	,	PUNCT
dhrp-35	40	4	therefore	therefore	ADV
dhrp-35	40	5	,	,	PUNCT
dhrp-35	40	6	imperative	imperative	ADJ
dhrp-35	40	7	that	that	SCONJ
dhrp-35	40	8	we	we	PRON
dhrp-35	40	9	continue	continue	VERB
dhrp-35	40	10	to	to	PART
dhrp-35	40	11	exercise	exercise	VERB
dhrp-35	40	12	extreme	extreme	ADJ
dhrp-35	40	13	caution	caution	NOUN
dhrp-35	40	14	in	in	ADP
dhrp-35	40	15	our	our	PRON
dhrp-35	40	16	social	social	ADJ
dhrp-35	40	17	congregations	congregation	NOUN
dhrp-35	40	18	and	and	CCONJ
dhrp-35	40	19	all	all	DET
dhrp-35	40	20	those	those	PRON
dhrp-35	40	21	who	who	PRON
dhrp-35	40	22	are	be	AUX
dhrp-35	40	23	eligible	eligible	ADJ
dhrp-35	40	24	must	must	AUX
dhrp-35	40	25	get	get	AUX
dhrp-35	40	26	vaccinated	vaccinate	VERB
dhrp-35	40	27	including	include	VERB
dhrp-35	40	28	the	the	DET
dhrp-35	40	29	third	third	ADJ
dhrp-35	40	30	and/or	and/or	CCONJ
dhrp-35	40	31	the	the	DET
dhrp-35	40	32	booster	booster	NOUN
dhrp-35	40	33	doses	dose	NOUN
dhrp-35	40	34	.	.	PUNCT
dhrp-35	41	1	diclosures	diclosure	VERB
dhrp-35	41	2	sr	sr	PROPN
dhrp-35	41	3	declares	declare	VERB
dhrp-35	41	4	no	no	DET
dhrp-35	41	5	conflicts	conflict	NOUN
dhrp-35	41	6	of	of	ADP
dhrp-35	41	7	interest	interest	NOUN
dhrp-35	41	8	.	.	PUNCT
dhrp-35	42	1	ms	ms	PROPN
dhrp-35	42	2	declares	declare	VERB
dhrp-35	42	3	no	no	DET
dhrp-35	42	4	conflicts	conflict	NOUN
dhrp-35	42	5	of	of	ADP
dhrp-35	42	6	interest	interest	NOUN
dhrp-35	42	7	.	.	PUNCT
dhrp-35	43	1	funding	fund	VERB
dhrp-35	43	2	the	the	DET
dhrp-35	43	3	project	project	NOUN
dhrp-35	43	4	is	be	AUX
dhrp-35	43	5	funded	fund	VERB
dhrp-35	43	6	by	by	ADP
dhrp-35	43	7	a	a	DET
dhrp-35	43	8	seed	seed	NOUN
dhrp-35	43	9	grant	grant	NOUN
dhrp-35	43	10	from	from	ADP
dhrp-35	43	11	the	the	DET
dhrp-35	43	12	dhr	dhr	PROPN
dhrp-35	43	13	health	health	PROPN
dhrp-35	43	14	institute	institute	PROPN
dhrp-35	43	15	for	for	ADP
dhrp-35	43	16	research	research	PROPN
dhrp-35	43	17	&	&	CCONJ
dhrp-35	43	18	development	development	PROPN
dhrp-35	43	19	references	reference	NOUN
dhrp-35	43	20	1	1	NUM
dhrp-35	43	21	.	.	PUNCT
dhrp-35	44	1	the	the	DET
dhrp-35	44	2	coronavirus	coronavirus	NOUN
dhrp-35	44	3	resource	resource	NOUN
dhrp-35	44	4	center	center	NOUN
dhrp-35	44	5	.	.	PUNCT
dhrp-35	45	1	the	the	DET
dhrp-35	45	2	johns	johns	PROPN
dhrp-35	45	3	hopkins	hopkins	PROPN
dhrp-35	45	4	university	university	PROPN
dhrp-35	45	5	.	.	PUNCT
dhrp-35	45	6	2021	2021	NUM
dhrp-35	45	7	.	.	PUNCT
dhrp-35	46	1	https://coronavirus.jhu.edu/map.html	https://coronavirus.jhu.edu/map.html	PROPN
dhrp-35	46	2	.	.	PUNCT
dhrp-35	47	1	(	(	PUNCT
dhrp-35	47	2	accessed	access	VERB
dhrp-35	47	3	november	november	PROPN
dhrp-35	47	4	26	26	NUM
dhrp-35	47	5	,	,	PUNCT
dhrp-35	47	6	2021	2021	NUM
dhrp-35	47	7	,	,	PUNCT
dhrp-35	47	8	at	at	ADP
dhrp-35	47	9	13:00	13:00	NUM
dhrp-35	47	10	hrs	hrs	NOUN
dhrp-35	47	11	)	)	PUNCT
dhrp-35	47	12	2	2	NUM
dhrp-35	47	13	.	.	X
dhrp-35	48	1	cdc	cdc	PROPN
dhrp-35	48	2	data	data	PROPN
dhrp-35	48	3	tracker	tracker	PROPN
dhrp-35	48	4	.	.	PUNCT
dhrp-35	49	1	monitoring	monitor	VERB
dhrp-35	49	2	variant	variant	ADJ
dhrp-35	49	3	proportions	proportion	NOUN
dhrp-35	49	4	.	.	PUNCT
dhrp-35	50	1	2021	2021	NUM
dhrp-35	50	2	https://covid.cdc.gov/covid-data-tracker/#variantproportions	https://covid.cdc.gov/covid-data-tracker/#variantproportion	NOUN
dhrp-35	50	3	(	(	PUNCT
dhrp-35	50	4	(	(	PUNCT
dhrp-35	50	5	accessed	access	VERB
dhrp-35	50	6	november	november	PROPN
dhrp-35	50	7	26	26	NUM
dhrp-35	50	8	,	,	PUNCT
dhrp-35	50	9	2021	2021	NUM
dhrp-35	50	10	,	,	PUNCT
dhrp-35	50	11	at	at	ADP
dhrp-35	50	12	14:00	14:00	NUM
dhrp-35	50	13	hrs	hrs	NOUN
dhrp-35	50	14	)	)	PUNCT
dhrp-35	50	15	)	)	PUNCT
dhrp-35	51	1	https://coronavirus.jhu.edu/map.html	https://coronavirus.jhu.edu/map.html	PROPN
dhrp-35	51	2	https://covid.cdc.gov/covid-data-tracker/#variant-proportions	https://covid.cdc.gov/covid-data-tracker/#variant-proportion	NOUN
dhrp-35	51	3	https://covid.cdc.gov/covid-data-tracker/#variant-proportions	https://covid.cdc.gov/covid-data-tracker/#variant-proportions	PROPN
dhrp-35	51	4	dhrp	dhrp	ADJ
dhrp-35	51	5	,	,	PUNCT
dhrp-35	51	6	2021	2021	NUM
dhrp-35	51	7	,	,	PUNCT
dhrp-35	51	8	vol	vol	NOUN
dhrp-35	51	9	.	.	NOUN
dhrp-35	51	10	1	1	NUM
dhrp-35	51	11	(	(	PUNCT
dhrp-35	51	12	s5	s5	NOUN
dhrp-35	51	13	)	)	PUNCT
dhrp-35	51	14	7	7	NUM
dhrp-35	51	15	-	-	SYM
dhrp-35	51	16	10	10	NUM
dhrp-35	51	17	the	the	DET
dhrp-35	51	18	b.1.1.529	b.1.1.529	ADJ
dhrp-35	51	19	(	(	PUNCT
dhrp-35	51	20	omicron	omicron	PROPN
dhrp-35	51	21	)	)	PUNCT
dhrp-35	51	22	variant	variant	NOUN
dhrp-35	51	23	of	of	ADP
dhrp-35	51	24	sars	sar	NOUN
dhrp-35	51	25	-	-	PUNCT
dhrp-35	51	26	cov-2	cov-2	NOUN
dhrp-35	51	27	http://dhrproceedings.org	http://dhrproceedings.org	PROPN
dhrp-35	51	28	10	10	NUM
dhrp-35	51	29	©	©	PROPN
dhrp-35	51	30	dhr	dhr	PROPN
dhrp-35	51	31	health	health	PROPN
dhrp-35	51	32	institute	institute	PROPN
dhrp-35	51	33	for	for	ADP
dhrp-35	51	34	research	research	NOUN
dhrp-35	51	35	and	and	CCONJ
dhrp-35	51	36	development	development	NOUN
dhrp-35	51	37	3	3	NUM
dhrp-35	51	38	.	.	PUNCT
dhrp-35	52	1	fda	fda	PROPN
dhrp-35	52	2	authorizes	authorize	VERB
dhrp-35	52	3	additional	additional	ADJ
dhrp-35	52	4	monoclonal	monoclonal	NOUN
dhrp-35	52	5	antibody	antibody	NOUN
dhrp-35	52	6	for	for	ADP
dhrp-35	52	7	treatment	treatment	NOUN
dhrp-35	52	8	of	of	ADP
dhrp-35	52	9	covid-19	covid-19	PROPN
dhrp-35	52	10	.	.	PROPN
dhrp-35	52	11	2021	2021	NUM
dhrp-35	52	12	.	.	PUNCT
dhrp-35	53	1	https://www.fda.gov/news-events/pressannouncements/coronavirus-covid-19-update-fdaauthorizes-additional-monoclonal-antibody-treatmentcovid-19	https://www.fda.gov/news-events/pressannouncements/coronavirus-covid-19-update-fdaauthorizes-additional-monoclonal-antibody-treatmentcovid-19	PROPN
dhrp-35	53	2	.	.	PUNCT
dhrp-35	54	1	(	(	PUNCT
dhrp-35	54	2	accessed	access	VERB
dhrp-35	54	3	november	november	PROPN
dhrp-35	54	4	26	26	NUM
dhrp-35	54	5	,	,	PUNCT
dhrp-35	54	6	2021	2021	NUM
dhrp-35	54	7	)	)	PUNCT
dhrp-35	54	8	.	.	PUNCT
dhrp-35	55	1	4	4	X
dhrp-35	55	2	.	.	X
dhrp-35	55	3	peacock	peacock	NOUN
dhrp-35	55	4	,	,	PUNCT
dhrp-35	55	5	t.	t.	PROPN
dhrp-35	55	6	b.1.1	b.1.1	PROPN
dhrp-35	55	7	descendant	descendant	NOUN
dhrp-35	55	8	associated	associate	VERB
dhrp-35	55	9	with	with	ADP
dhrp-35	55	10	southern	southern	PROPN
dhrp-35	55	11	africa	africa	PROPN
dhrp-35	55	12	with	with	ADP
dhrp-35	55	13	high	high	ADJ
dhrp-35	55	14	number	number	NOUN
dhrp-35	55	15	of	of	ADP
dhrp-35	55	16	spike	spike	ADJ
dhrp-35	55	17	mutations	mutation	NOUN
dhrp-35	55	18	.	.	PUNCT
dhrp-35	56	1	2021	2021	NUM
dhrp-35	56	2	.	.	PUNCT
dhrp-35	57	1	github	github	PROPN
dhrp-35	57	2	.	.	PUNCT
dhrp-35	58	1	https://github.com/cov-lineages/pangodesignation/issues/343	https://github.com/cov-lineages/pangodesignation/issues/343	NOUN
dhrp-35	58	2	.	.	PUNCT
dhrp-35	59	1	5	5	X
dhrp-35	59	2	.	.	X
dhrp-35	59	3	cheng	cheng	PROPN
dhrp-35	59	4	,	,	PUNCT
dhrp-35	59	5	m.	m.	NOUN
dhrp-35	59	6	what	what	PRON
dhrp-35	59	7	is	be	AUX
dhrp-35	59	8	this	this	DET
dhrp-35	59	9	new	new	ADJ
dhrp-35	59	10	covid	covid	NOUN
dhrp-35	59	11	variant	variant	NOUN
dhrp-35	59	12	in	in	ADP
dhrp-35	59	13	south	south	PROPN
dhrp-35	59	14	africa	africa	PROPN
dhrp-35	59	15	.	.	PUNCT
dhrp-35	60	1	november	november	PROPN
dhrp-35	60	2	26	26	NUM
dhrp-35	60	3	,	,	PUNCT
dhrp-35	60	4	2021	2021	NUM
dhrp-35	60	5	.	.	PUNCT
dhrp-35	61	1	associated	associated	ADJ
dhrp-35	61	2	press	press	NOUN
dhrp-35	61	3	.	.	PUNCT
dhrp-35	62	1	https://www.aol.com/explainer-covid-variant-southafrica-111307372-142856393.html	https://www.aol.com/explainer-covid-variant-southafrica-111307372-142856393.html	PROPN
dhrp-35	62	2	6	6	NUM
dhrp-35	62	3	.	.	PUNCT
dhrp-35	63	1	classification	classification	NOUN
dhrp-35	63	2	of	of	ADP
dhrp-35	63	3	omicron	omicron	PROPN
dhrp-35	63	4	(	(	PUNCT
dhrp-35	63	5	b.1.1.529	b.1.1.529	ADV
dhrp-35	63	6	):	):	PUNCT
dhrp-35	63	7	sars	sar	NOUN
dhrp-35	63	8	-	-	PUNCT
dhrp-35	63	9	cov-2	cov-2	NOUN
dhrp-35	63	10	variant	variant	NOUN
dhrp-35	63	11	of	of	ADP
dhrp-35	63	12	concern	concern	NOUN
dhrp-35	63	13	.	.	PUNCT
dhrp-35	64	1	world	world	NOUN
dhrp-35	64	2	health	health	PROPN
dhrp-35	64	3	organization	organization	PROPN
dhrp-35	64	4	.	.	PUNCT
dhrp-35	65	1	november	november	PROPN
dhrp-35	65	2	26	26	NUM
dhrp-35	65	3	,	,	PUNCT
dhrp-35	65	4	2021	2021	NUM
dhrp-35	65	5	.	.	PUNCT
dhrp-35	66	1	https://www.who.int/news/item/26-11-2021classification-of-omicron-(b.1.1.529)-sars-cov-2variant-of-concern	https://www.who.int/news/item/26-11-2021classification-of-omicron-(b.1.1.529)-sars-cov-2variant-of-concern	PROPN
dhrp-35	66	2	7	7	X
dhrp-35	66	3	.	.	PUNCT
dhrp-35	66	4	statement	statement	NOUN
dhrp-35	66	5	from	from	ADP
dhrp-35	66	6	president	president	PROPN
dhrp-35	66	7	joe	joe	PROPN
dhrp-35	66	8	biden	biden	PROPN
dhrp-35	66	9	on	on	ADP
dhrp-35	66	10	the	the	DET
dhrp-35	66	11	omicron	omicron	PROPN
dhrp-35	66	12	covid-19	covid-19	PROPN
dhrp-35	66	13	variant	variant	NOUN
dhrp-35	66	14	.	.	PUNCT
dhrp-35	67	1	the	the	DET
dhrp-35	67	2	white	white	PROPN
dhrp-35	67	3	house	house	PROPN
dhrp-35	67	4	.	.	PUNCT
dhrp-35	68	1	november	november	PROPN
dhrp-35	68	2	26	26	NUM
dhrp-35	68	3	,	,	PUNCT
dhrp-35	68	4	2021	2021	NUM
dhrp-35	68	5	.	.	PUNCT
dhrp-35	69	1	https://www.whitehouse.gov/briefingroom/statements-releases/2021/11/26/statement-bypresident-joe-biden-on-the-omicron-covid-19-variant/	https://www.whitehouse.gov/briefingroom/statements-releases/2021/11/26/statement-bypresident-joe-biden-on-the-omicron-covid-19-variant/	PROPN
dhrp-35	70	1	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-monoclonal-antibody-treatment-covid-19	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-monoclonal-antibody-treatment-covid-19	INTJ
dhrp-35	70	2	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-monoclonal-antibody-treatment-covid-19	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-monoclonal-antibody-treatment-covid-19	CCONJ
dhrp-35	71	1	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-monoclonal-antibody-treatment-covid-19	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-monoclonal-antibody-treatment-covid-19	CCONJ
dhrp-35	72	1	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-monoclonal-antibody-treatment-covid-19	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-monoclonal-antibody-treatment-covid-19	ADV
dhrp-35	73	1	https://github.com/cov-lineages/pango-designation/issues/343	https://github.com/cov-lineages/pango-designation/issues/343	PROPN
dhrp-35	73	2	https://github.com/cov-lineages/pango-designation/issues/343	https://github.com/cov-lineages/pango-designation/issues/343	PROPN
dhrp-35	73	3	https://www.aol.com/explainer-covid-variant-south-africa-111307372-142856393.html	https://www.aol.com/explainer-covid-variant-south-africa-111307372-142856393.html	PROPN
dhrp-35	73	4	https://www.aol.com/explainer-covid-variant-south-africa-111307372-142856393.html	https://www.aol.com/explainer-covid-variant-south-africa-111307372-142856393.html	PROPN
dhrp-35	73	5	https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern	https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern	PROPN
dhrp-35	73	6	https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern	https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern	PROPN
dhrp-35	73	7	https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern	https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern	PROPN
dhrp-35	73	8	https://www.whitehouse.gov/briefing-room/statements-releases/2021/11/26/statement-by-president-joe-biden-on-the-omicron-covid-19-variant/	https://www.whitehouse.gov/briefing-room/statements-releases/2021/11/26/statement-by-president-joe-biden-on-the-omicron-covid-19-variant/	PROPN
dhrp-35	73	9	https://www.whitehouse.gov/briefing-room/statements-releases/2021/11/26/statement-by-president-joe-biden-on-the-omicron-covid-19-variant/	https://www.whitehouse.gov/briefing-room/statements-releases/2021/11/26/statement-by-president-joe-biden-on-the-omicron-covid-19-variant/	X
dhrp-35	73	10	https://www.whitehouse.gov/briefing-room/statements-releases/2021/11/26/statement-by-president-joe-biden-on-the-omicron-covid-19-variant/	https://www.whitehouse.gov/briefing-room/statements-releases/2021/11/26/statement-by-president-joe-biden-on-the-omicron-covid-19-variant/	X